,approvedSymbol,approvedName,prefName,drugType,drugId,phase,ctIds,id,disease
0,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
1,POLE2,"DNA polymerase epsilon 2, accessory subunit",CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
2,CHRM3,cholinergic receptor muscarinic 3,ATROPINE,Small molecule,CHEMBL517712,4.0,[],MONDO_0005180,Parkinson disease
3,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
4,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
5,DRD3,dopamine receptor D3,BROMOCRIPTINE MESYLATE,Small molecule,CHEMBL1200503,4.0,[],MONDO_0005180,Parkinson disease
6,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,4.0,"['NCT00174239', 'NCT00642356']",MONDO_0005180,Parkinson disease
7,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
8,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT01108029', 'NCT00646204']",MONDO_0005180,Parkinson disease
9,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,4.0,['NCT00477802'],MONDO_0005180,Parkinson disease
10,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
11,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
12,SCN3A,sodium voltage-gated channel alpha subunit 3,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
13,CACNA1B,calcium voltage-gated channel subunit alpha1 B,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00584025'],MONDO_0005180,Parkinson disease
14,SCN1A,sodium voltage-gated channel alpha subunit 1,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
15,ADRA1A,adrenoceptor alpha 1A,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
16,SLC6A2,solute carrier family 6 member 2,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT01244269'],MONDO_0005180,Parkinson disease
17,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,['NCT04952194'],MONDO_0005180,Parkinson disease
18,SCN10A,sodium voltage-gated channel alpha subunit 10,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
19,DRD4,dopamine receptor D4,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0005180,Parkinson disease
20,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
21,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
22,ADRA2A,adrenoceptor alpha 2A,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
23,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
24,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
25,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,4.0,['NCT02549573'],MONDO_0005180,Parkinson disease
26,GABRD,gamma-aminobutyric acid type A receptor subunit delta,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
27,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT00632762', 'NCT04387773']",MONDO_0005180,Parkinson disease
28,SCN9A,sodium voltage-gated channel alpha subunit 9,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
29,PRIM2,DNA primase subunit 2,CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
30,CHRM1,cholinergic receptor muscarinic 1,TRIHEXYPHENIDYL,Small molecule,CHEMBL1490,4.0,[],MONDO_0005180,Parkinson disease
31,DRD4,dopamine receptor D4,BROMOCRIPTINE MESYLATE,Small molecule,CHEMBL1200503,4.0,[],MONDO_0005180,Parkinson disease
32,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
33,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
34,AVPR1A,arginine vasopressin receptor 1A,DESMOPRESSIN ACETATE,Protein,CHEMBL1200556,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
35,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
36,DRD3,dopamine receptor D3,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,[],MONDO_0005180,Parkinson disease
37,HRH1,histamine receptor H1,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
38,DRD3,dopamine receptor D3,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,"['NCT02233023', 'NCT01673724']",MONDO_0005180,Parkinson disease
39,POLD1,"DNA polymerase delta 1, catalytic subunit",CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
40,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
41,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,[],MONDO_0005180,Parkinson disease
42,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02688465', 'NCT02549573']",MONDO_0005180,Parkinson disease
43,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,4.0,[],MONDO_0005180,Parkinson disease
44,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
45,HRH1,histamine receptor H1,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
46,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
47,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,"['NCT00174239', 'NCT00642356']",MONDO_0005180,Parkinson disease
48,DRD2,dopamine receptor D2,DOMPERIDONE,Small molecule,CHEMBL219916,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
49,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
50,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,4.0,['NCT01770145'],MONDO_0005180,Parkinson disease
51,DRD5,dopamine receptor D5,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0005180,Parkinson disease
52,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02688465', 'NCT02549573']",MONDO_0005180,Parkinson disease
53,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
54,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT01108029', 'NCT00646204']",MONDO_0005180,Parkinson disease
55,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
56,SCN3A,sodium voltage-gated channel alpha subunit 3,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
57,MTNR1A,melatonin receptor 1A,MELATONIN,Small molecule,CHEMBL45,4.0,"['NCT03258294', 'NCT02768077']",MONDO_0005180,Parkinson disease
58,POLA2,"DNA polymerase alpha 2, accessory subunit",CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
59,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,4.0,[],MONDO_0005180,Parkinson disease
60,DRD2,dopamine receptor D2,QUETIAPINE,Small molecule,CHEMBL716,4.0,['NCT04373317'],MONDO_0005180,Parkinson disease
61,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
62,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,4.0,[],MONDO_0005180,Parkinson disease
63,MAOB,monoamine oxidase B,SAFINAMIDE MESYLATE,Small molecule,CHEMBL48582,4.0,[],MONDO_0005180,Parkinson disease
64,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
65,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
66,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT04887467'],MONDO_0005180,Parkinson disease
67,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
68,MTNR1B,melatonin receptor 1B,MELATONIN,Small molecule,CHEMBL45,4.0,"['NCT02768077', 'NCT03258294']",MONDO_0005180,Parkinson disease
69,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,4.0,['NCT04373317'],MONDO_0005180,Parkinson disease
70,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
71,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
72,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT00632762', 'NCT04387773', 'NCT01071395', 'NCT01313845']",MONDO_0005180,Parkinson disease
73,SCN5A,sodium voltage-gated channel alpha subunit 5,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
74,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
75,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT01770145'],MONDO_0005180,Parkinson disease
76,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,"['NCT00888186', 'NCT00219284', 'NCT00141518', 'NCT00590122', 'NCT00906828', 'NCT00143026', 'NCT00125567', 'NCT00391898', 'NCT03115827']",MONDO_0005180,Parkinson disease
77,SCN8A,sodium voltage-gated channel alpha subunit 8,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
78,DRD1,dopamine receptor D1,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0005180,Parkinson disease
79,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
80,CHRM1,cholinergic receptor muscarinic 1,METHIXENE,Small molecule,CHEMBL1201342,4.0,[],MONDO_0005180,Parkinson disease
81,SCN8A,sodium voltage-gated channel alpha subunit 8,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
82,MAOB,monoamine oxidase B,RASAGILINE MESYLATE,Small molecule,CHEMBL1201142,4.0,['NCT00399477'],MONDO_0005180,Parkinson disease
83,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,"['NCT01673724', 'NCT00402233', 'NCT00321854', 'NCT02233023', 'NCT02231905', 'NCT03521635']",MONDO_0005180,Parkinson disease
84,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,4.0,['NCT02549573'],MONDO_0005180,Parkinson disease
85,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,[],MONDO_0005180,Parkinson disease
86,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
87,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,[],MONDO_0005180,Parkinson disease
88,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
89,DRD3,dopamine receptor D3,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,['NCT00485069'],MONDO_0005180,Parkinson disease
90,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,[],MONDO_0005180,Parkinson disease
91,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01048229'],MONDO_0005180,Parkinson disease
92,ACHE,acetylcholinesterase (Cartwright blood group),RIVASTIGMINE,Small molecule,CHEMBL636,4.0,['NCT01856738'],MONDO_0005180,Parkinson disease
93,POLD3,"DNA polymerase delta 3, accessory subunit",CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
94,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
95,ADRA2B,adrenoceptor alpha 2B,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT05376761'],MONDO_0005180,Parkinson disease
96,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,4.0,[],MONDO_0005180,Parkinson disease
97,SCN5A,sodium voltage-gated channel alpha subunit 5,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
98,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,[],MONDO_0005180,Parkinson disease
99,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,4.0,[],MONDO_0005180,Parkinson disease
100,DRD3,dopamine receptor D3,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0005180,Parkinson disease
101,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,['NCT04821687'],MONDO_0005180,Parkinson disease
102,ACHE,acetylcholinesterase (Cartwright blood group),DONEPEZIL,Small molecule,CHEMBL502,4.0,"['NCT01521117', 'NCT00030979']",MONDO_0005180,Parkinson disease
103,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
104,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,"['NCT02549573', 'NCT02688465']",MONDO_0005180,Parkinson disease
105,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
106,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT02231905'],MONDO_0005180,Parkinson disease
107,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
108,AVPR2,arginine vasopressin receptor 2,DESMOPRESSIN,Protein,CHEMBL1429,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
109,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,4.0,"['NCT01485172', 'NCT00986245', 'NCT00485069', 'NCT01494532']",MONDO_0005180,Parkinson disease
110,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
111,ACHE,acetylcholinesterase (Cartwright blood group),RIVASTIGMINE,Small molecule,CHEMBL636,4.0,[],MONDO_0005180,Parkinson disease
112,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
113,SCN3A,sodium voltage-gated channel alpha subunit 3,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
114,CHRM1,cholinergic receptor muscarinic 1,ETHOPROPAZINE,Small molecule,CHEMBL1206,4.0,[],MONDO_0005180,Parkinson disease
115,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,"['NCT00696215', 'NCT01007630', 'NCT01385735', 'NCT01765257']",MONDO_0005180,Parkinson disease
116,DDC,dopa decarboxylase,BENSERAZIDE,Small molecule,CHEMBL1096979,4.0,['NCT02741947'],MONDO_0005180,Parkinson disease
117,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
118,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,['NCT00601978'],MONDO_0005180,Parkinson disease
119,SCN11A,sodium voltage-gated channel alpha subunit 11,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
120,SCN4A,sodium voltage-gated channel alpha subunit 4,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
121,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,[],MONDO_0005180,Parkinson disease
122,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
123,DRD4,dopamine receptor D4,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,[],MONDO_0005180,Parkinson disease
124,SCN2A,sodium voltage-gated channel alpha subunit 2,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
125,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
126,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
127,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,"['NCT04986995', 'NCT04990284']",MONDO_0005180,Parkinson disease
128,ACHE,acetylcholinesterase (Cartwright blood group),RIVASTIGMINE TARTRATE,Small molecule,CHEMBL215645,4.0,[],MONDO_0005180,Parkinson disease
129,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN TARTRATE,Small molecule,CHEMBL2448613,4.0,[],MONDO_0005180,Parkinson disease
130,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT01108029', 'NCT00646204']",MONDO_0005180,Parkinson disease
131,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
132,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,"['NCT00402233', 'NCT00321854', 'NCT01673724', 'NCT02231905', 'NCT02233023', 'NCT03521635']",MONDO_0005180,Parkinson disease
133,CHRM1,cholinergic receptor muscarinic 1,PROCYCLIDINE,Small molecule,CHEMBL86715,4.0,[],MONDO_0005180,Parkinson disease
134,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,VARENICLINE,Small molecule,CHEMBL1396,4.0,['NCT02473562'],MONDO_0005180,Parkinson disease
135,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
136,COMT,catechol-O-methyltransferase,TOLCAPONE,Small molecule,CHEMBL1324,4.0,[],MONDO_0005180,Parkinson disease
137,CHRM1,cholinergic receptor muscarinic 1,ATROPINE,Small molecule,CHEMBL517712,4.0,[],MONDO_0005180,Parkinson disease
138,CHRM1,cholinergic receptor muscarinic 1,BENZTROPINE MESYLATE,Small molecule,CHEMBL1200383,4.0,[],MONDO_0005180,Parkinson disease
139,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,"['NCT04990284', 'NCT02480803']",MONDO_0005180,Parkinson disease
140,ADRA2A,adrenoceptor alpha 2A,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT05376761'],MONDO_0005180,Parkinson disease
141,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,4.0,"['NCT00219284', 'NCT00391898', 'NCT00906828', 'NCT00888186', 'NCT00125567', 'NCT00143026', 'NCT00590122', 'NCT00141518', 'NCT03115827']",MONDO_0005180,Parkinson disease
142,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0005180,Parkinson disease
143,POLD2,"DNA polymerase delta 2, accessory subunit",CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
144,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT02940912'],MONDO_0005180,Parkinson disease
145,BCHE,butyrylcholinesterase,RIVASTIGMINE TARTRATE,Small molecule,CHEMBL215645,4.0,[],MONDO_0005180,Parkinson disease
146,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
147,ADRA2B,adrenoceptor alpha 2B,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT02982512'],MONDO_0005180,Parkinson disease
148,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
149,SCN7A,sodium voltage-gated channel alpha subunit 7,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
150,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
151,SCN8A,sodium voltage-gated channel alpha subunit 8,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
152,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT02940912'],MONDO_0005180,Parkinson disease
153,HTR2C,5-hydroxytryptamine receptor 2C,METHIXENE,Small molecule,CHEMBL1201342,4.0,[],MONDO_0005180,Parkinson disease
154,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
155,SLC6A3,solute carrier family 6 member 3,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT00526630'],MONDO_0005180,Parkinson disease
156,SCN10A,sodium voltage-gated channel alpha subunit 10,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
157,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
158,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,[],MONDO_0005180,Parkinson disease
159,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01071395', 'NCT00632762', 'NCT01313845', 'NCT04387773']",MONDO_0005180,Parkinson disease
160,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01071395', 'NCT04387773', 'NCT00632762', 'NCT01313845']",MONDO_0005180,Parkinson disease
161,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
162,COMT,catechol-O-methyltransferase,TOLCAPONE,Small molecule,CHEMBL1324,4.0,['NCT00906828'],MONDO_0005180,Parkinson disease
163,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,4.0,"['NCT00485069', 'NCT01485172', 'NCT00986245', 'NCT01494532']",MONDO_0005180,Parkinson disease
164,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01071395', 'NCT00632762', 'NCT04387773', 'NCT01313845']",MONDO_0005180,Parkinson disease
165,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,4.0,[],MONDO_0005180,Parkinson disease
166,POLA1,"DNA polymerase alpha 1, catalytic subunit",CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
167,CHRM3,cholinergic receptor muscarinic 3,ATROPINE SULFATE,Small molecule,CHEMBL2146146,4.0,[],MONDO_0005180,Parkinson disease
168,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
169,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,4.0,['NCT02480803'],MONDO_0005180,Parkinson disease
170,HTR2C,5-hydroxytryptamine receptor 2C,QUETIAPINE,Small molecule,CHEMBL716,4.0,['NCT04373317'],MONDO_0005180,Parkinson disease
171,CHRM2,cholinergic receptor muscarinic 2,ATROPINE SULFATE,Small molecule,CHEMBL2146146,4.0,[],MONDO_0005180,Parkinson disease
172,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01048229'],MONDO_0005180,Parkinson disease
173,AVPR1B,arginine vasopressin receptor 1B,DESMOPRESSIN ACETATE,Protein,CHEMBL1200556,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
174,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
175,SV2A,synaptic vesicle glycoprotein 2A,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00307450'],MONDO_0005180,Parkinson disease
176,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
177,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,[],MONDO_0005180,Parkinson disease
178,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
179,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,[],MONDO_0005180,Parkinson disease
180,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,4.0,[],MONDO_0005180,Parkinson disease
181,DRD2,dopamine receptor D2,BROMOCRIPTINE MESYLATE,Small molecule,CHEMBL1200503,4.0,[],MONDO_0005180,Parkinson disease
182,AVPR1A,arginine vasopressin receptor 1A,DESMOPRESSIN,Protein,CHEMBL1429,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
183,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
184,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,4.0,['NCT00601978'],MONDO_0005180,Parkinson disease
185,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
186,SLC6A2,solute carrier family 6 member 2,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
187,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT04887467'],MONDO_0005180,Parkinson disease
188,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
189,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,4.0,[],MONDO_0005180,Parkinson disease
190,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
191,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
192,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,4.0,['NCT01770145'],MONDO_0005180,Parkinson disease
193,SCN11A,sodium voltage-gated channel alpha subunit 11,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
194,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,['NCT01519882'],MONDO_0005180,Parkinson disease
195,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
196,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,4.0,[],MONDO_0005180,Parkinson disease
197,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
198,SCN10A,sodium voltage-gated channel alpha subunit 10,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
199,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
200,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT04887467'],MONDO_0005180,Parkinson disease
201,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
202,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
203,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,4.0,['NCT01770145'],MONDO_0005180,Parkinson disease
204,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0005180,Parkinson disease
205,MAOB,monoamine oxidase B,RASAGILINE MESYLATE,Small molecule,CHEMBL1201142,4.0,[],MONDO_0005180,Parkinson disease
206,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,4.0,"['NCT01494532', 'NCT00485069', 'NCT00986245', 'NCT01485172']",MONDO_0005180,Parkinson disease
207,CHRM1,cholinergic receptor muscarinic 1,BENZTROPINE,Small molecule,CHEMBL1201203,4.0,[],MONDO_0005180,Parkinson disease
208,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,[],MONDO_0005180,Parkinson disease
209,SCN7A,sodium voltage-gated channel alpha subunit 7,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
210,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,[],MONDO_0005180,Parkinson disease
211,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,"['NCT00125567', 'NCT02847442', 'NCT00247247', 'NCT00143026', 'NCT00391898', 'NCT00373087', 'NCT00219284', 'NCT00906828']",MONDO_0005180,Parkinson disease
212,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,4.0,"['NCT03840837', 'NCT00988117', 'NCT01340885']",MONDO_0005180,Parkinson disease
213,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0005180,Parkinson disease
214,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,[],MONDO_0005180,Parkinson disease
215,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
216,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,4.0,['NCT04986982'],MONDO_0005180,Parkinson disease
217,SLC6A2,solute carrier family 6 member 2,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT00526630'],MONDO_0005180,Parkinson disease
218,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
219,SV2A,synaptic vesicle glycoprotein 2A,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00584025'],MONDO_0005180,Parkinson disease
220,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,"['NCT01048229', 'NCT01178047']",MONDO_0005180,Parkinson disease
221,VDR,vitamin D receptor,CHOLECALCIFEROL,Small molecule,CHEMBL1042,4.0,['NCT00571285'],MONDO_0005180,Parkinson disease
222,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT02231905'],MONDO_0005180,Parkinson disease
223,ACHE,acetylcholinesterase (Cartwright blood group),RIVASTIGMINE,Small molecule,CHEMBL636,4.0,"['NCT03840837', 'NCT01340885', 'NCT00988117']",MONDO_0005180,Parkinson disease
224,ADRA2A,adrenoceptor alpha 2A,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT02256319', 'NCT01721460', 'NCT01789385']",MONDO_0005180,Parkinson disease
225,DRD4,dopamine receptor D4,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,[],MONDO_0005180,Parkinson disease
226,PRIM1,DNA primase subunit 1,CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
227,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,"['NCT01770145', 'NCT02847442', 'NCT00590122', 'NCT00914134', 'NCT00391898', 'NCT00399477', 'NCT00272688', 'NCT00141518', 'NCT00888186', 'NCT00906828', 'NCT02741947', 'NCT00125567', 'NCT00485069', 'NCT00143026', 'NCT00153972', 'NCT00219284', 'NCT02769793']",MONDO_0005180,Parkinson disease
228,DRD2,dopamine receptor D2,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,['NCT00485069'],MONDO_0005180,Parkinson disease
229,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,4.0,['NCT01856738'],MONDO_0005180,Parkinson disease
230,HTR2A,5-hydroxytryptamine receptor 2A,QUETIAPINE,Small molecule,CHEMBL716,4.0,['NCT04373317'],MONDO_0005180,Parkinson disease
231,DRD2,dopamine receptor D2,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,[],MONDO_0005180,Parkinson disease
232,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,['NCT00601978'],MONDO_0005180,Parkinson disease
233,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,4.0,"['NCT02233023', 'NCT00590122', 'NCT03151460']",MONDO_0005180,Parkinson disease
234,SCN1A,sodium voltage-gated channel alpha subunit 1,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
235,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
236,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT00632762', 'NCT04387773']",MONDO_0005180,Parkinson disease
237,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
238,AVPR2,arginine vasopressin receptor 2,DESMOPRESSIN ACETATE,Protein,CHEMBL1200556,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
239,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
240,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,[],MONDO_0005180,Parkinson disease
241,ADRA2A,adrenoceptor alpha 2A,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT02982512'],MONDO_0005180,Parkinson disease
242,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,4.0,"['NCT03843944', 'NCT03841604']",MONDO_0005180,Parkinson disease
243,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
244,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01048229'],MONDO_0005180,Parkinson disease
245,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,['NCT02480803'],MONDO_0005180,Parkinson disease
246,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
247,ADRA2C,adrenoceptor alpha 2C,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT02982512'],MONDO_0005180,Parkinson disease
248,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
249,SCN5A,sodium voltage-gated channel alpha subunit 5,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
250,ADRA1B,adrenoceptor alpha 1B,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
251,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,['NCT01519882'],MONDO_0005180,Parkinson disease
252,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
253,ADRA2B,adrenoceptor alpha 2B,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT01721460', 'NCT02256319', 'NCT01789385']",MONDO_0005180,Parkinson disease
254,DRD4,dopamine receptor D4,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,['NCT00485069'],MONDO_0005180,Parkinson disease
255,SCN11A,sodium voltage-gated channel alpha subunit 11,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
256,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,4.0,[],MONDO_0005180,Parkinson disease
257,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
258,DRD2,dopamine receptor D2,CABERGOLINE,Small molecule,CHEMBL1201087,4.0,['NCT00153972'],MONDO_0005180,Parkinson disease
259,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
260,ADRB3,adrenoceptor beta 3,MIRABEGRON,Small molecule,CHEMBL2095212,4.0,['NCT02092181'],MONDO_0005180,Parkinson disease
261,DRD2,dopamine receptor D2,PERGOLIDE,Small molecule,CHEMBL531,4.0,[],MONDO_0005180,Parkinson disease
262,DRD2,dopamine receptor D2,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,[],MONDO_0005180,Parkinson disease
263,SLC6A3,solute carrier family 6 member 3,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT01244269'],MONDO_0005180,Parkinson disease
264,CHRM1,cholinergic receptor muscarinic 1,BIPERIDEN,Small molecule,CHEMBL1101,4.0,[],MONDO_0005180,Parkinson disease
265,MAOB,monoamine oxidase B,SELEGILINE,Small molecule,CHEMBL972,4.0,"['NCT00640159', 'NCT00443872', 'NCT04870372']",MONDO_0005180,Parkinson disease
266,SCN4A,sodium voltage-gated channel alpha subunit 4,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
267,ADRB3,adrenoceptor beta 3,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
268,CACNA1B,calcium voltage-gated channel subunit alpha1 B,LEVETIRACETAM,Small molecule,CHEMBL1286,4.0,['NCT00307450'],MONDO_0005180,Parkinson disease
269,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,['NCT00601978'],MONDO_0005180,Parkinson disease
270,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,"['NCT01744496', 'NCT01300819', 'NCT01782222', 'NCT03103919', 'NCT00594464', 'NCT01711866', 'NCT01523301']",MONDO_0005180,Parkinson disease
271,ADRA2C,adrenoceptor alpha 2C,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
272,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01313845', 'NCT04387773', 'NCT00632762', 'NCT01071395']",MONDO_0005180,Parkinson disease
273,SCN2A,sodium voltage-gated channel alpha subunit 2,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
274,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
275,DRD3,dopamine receptor D3,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,4.0,[],MONDO_0005180,Parkinson disease
276,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,4.0,[],MONDO_0005180,Parkinson disease
277,ACHE,acetylcholinesterase (Cartwright blood group),DONEPEZIL,Small molecule,CHEMBL502,4.0,['NCT03011476'],MONDO_0005180,Parkinson disease
278,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,['NCT04952194'],MONDO_0005180,Parkinson disease
279,DRD4,dopamine receptor D4,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,"['NCT02233023', 'NCT01673724']",MONDO_0005180,Parkinson disease
280,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,['NCT00642356'],MONDO_0005180,Parkinson disease
281,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,"['NCT04387773', 'NCT00632762']",MONDO_0005180,Parkinson disease
282,SCN9A,sodium voltage-gated channel alpha subunit 9,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
283,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,VARENICLINE,Small molecule,CHEMBL1396,4.0,['NCT02473562'],MONDO_0005180,Parkinson disease
284,GABRP,gamma-aminobutyric acid type A receptor subunit pi,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
285,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,4.0,[],MONDO_0005180,Parkinson disease
286,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
287,ADRB1,adrenoceptor beta 1,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
288,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT01770145'],MONDO_0005180,Parkinson disease
289,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,[],MONDO_0005180,Parkinson disease
290,SCN1A,sodium voltage-gated channel alpha subunit 1,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
291,SCN9A,sodium voltage-gated channel alpha subunit 9,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
292,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT00632762', 'NCT04387773', 'NCT01313845', 'NCT01071395']",MONDO_0005180,Parkinson disease
293,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,4.0,['NCT02472210'],MONDO_0005180,Parkinson disease
294,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,"['NCT01300819', 'NCT01782222', 'NCT01744496', 'NCT01711866', 'NCT01523301', 'NCT00594464', 'NCT03103919']",MONDO_0005180,Parkinson disease
295,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
296,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,"['NCT02231905', 'NCT00402233', 'NCT00321854', 'NCT02233023', 'NCT03521635', 'NCT01673724']",MONDO_0005180,Parkinson disease
297,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,['NCT01519882'],MONDO_0005180,Parkinson disease
298,POLD4,"DNA polymerase delta 4, accessory subunit",CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
299,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,[],MONDO_0005180,Parkinson disease
300,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,4.0,[],MONDO_0005180,Parkinson disease
301,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,MEMANTINE,Small molecule,CHEMBL807,4.0,"['NCT00646204', 'NCT01108029']",MONDO_0005180,Parkinson disease
302,AVPR1B,arginine vasopressin receptor 1B,DESMOPRESSIN,Protein,CHEMBL1429,4.0,['NCT00806468'],MONDO_0005180,Parkinson disease
303,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
304,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,4.0,[],MONDO_0005180,Parkinson disease
305,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT02940912'],MONDO_0005180,Parkinson disease
306,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,NICOTINE,Small molecule,CHEMBL3,4.0,['NCT01216904'],MONDO_0005180,Parkinson disease
307,DRD2,dopamine receptor D2,CABERGOLINE,Small molecule,CHEMBL1201087,4.0,['NCT00174239'],MONDO_0005180,Parkinson disease
308,ADRA2B,adrenoceptor alpha 2B,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
309,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT02231905'],MONDO_0005180,Parkinson disease
310,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,NICOTINE,Small molecule,CHEMBL3,4.0,['NCT01216904'],MONDO_0005180,Parkinson disease
311,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
312,ADRA2C,adrenoceptor alpha 2C,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT02256319', 'NCT01721460', 'NCT01789385']",MONDO_0005180,Parkinson disease
313,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
314,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,4.0,"['NCT01313845', 'NCT04387773', 'NCT01071395', 'NCT00632762']",MONDO_0005180,Parkinson disease
315,SLC6A2,solute carrier family 6 member 2,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
316,MTNR1B,melatonin receptor 1B,RAMELTEON,Small molecule,CHEMBL1218,4.0,['NCT00462254'],MONDO_0005180,Parkinson disease
317,DRD2,dopamine receptor D2,BROMOCRIPTINE,Small molecule,CHEMBL493,4.0,"['NCT02233023', 'NCT01673724']",MONDO_0005180,Parkinson disease
318,SCN2A,sodium voltage-gated channel alpha subunit 2,ORPHENADRINE,Small molecule,CHEMBL900,4.0,[],MONDO_0005180,Parkinson disease
319,ADRA2C,adrenoceptor alpha 2C,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,['NCT05376761'],MONDO_0005180,Parkinson disease
320,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,4.0,['NCT01770145'],MONDO_0005180,Parkinson disease
321,POLE3,"DNA polymerase epsilon 3, accessory subunit",CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
322,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
323,SCN7A,sodium voltage-gated channel alpha subunit 7,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
324,ADRB2,adrenoceptor beta 2,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
325,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,4.0,[],MONDO_0005180,Parkinson disease
326,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,ORPHENADRINE HYDROCHLORIDE,Small molecule,CHEMBL1201023,4.0,[],MONDO_0005180,Parkinson disease
327,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,4.0,[],MONDO_0005180,Parkinson disease
328,ADRA1D,adrenoceptor alpha 1D,DROXIDOPA,Small molecule,CHEMBL2103827,4.0,['NCT03115827'],MONDO_0005180,Parkinson disease
329,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,4.0,['NCT02549573'],MONDO_0005180,Parkinson disease
330,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,4.0,['NCT05312632'],MONDO_0005180,Parkinson disease
331,CHRM1,cholinergic receptor muscarinic 1,ATROPINE SULFATE,Small molecule,CHEMBL2146146,4.0,[],MONDO_0005180,Parkinson disease
332,MTNR1A,melatonin receptor 1A,RAMELTEON,Small molecule,CHEMBL1218,4.0,['NCT00462254'],MONDO_0005180,Parkinson disease
333,SLC6A2,solute carrier family 6 member 2,ATOMOXETINE,Small molecule,CHEMBL641,4.0,['NCT01340885'],MONDO_0005180,Parkinson disease
334,SCN4A,sodium voltage-gated channel alpha subunit 4,ZONISAMIDE,Small molecule,CHEMBL750,4.0,['NCT03034538'],MONDO_0005180,Parkinson disease
335,POLE,"DNA polymerase epsilon, catalytic subunit",CYTARABINE,Small molecule,CHEMBL803,4.0,['NCT03022201'],MONDO_0005180,Parkinson disease
336,MAOB,monoamine oxidase B,SELEGILINE,Small molecule,CHEMBL972,4.0,[],MONDO_0005180,Parkinson disease
337,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,4.0,[],MONDO_0005180,Parkinson disease
338,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,4.0,"['NCT00755027', 'NCT01382342', 'NCT01497652', 'NCT00902941', 'NCT01049984', 'NCT01723228', 'NCT00399477', 'NCT01168596']",MONDO_0005180,Parkinson disease
339,MAOB,monoamine oxidase B,SAFINAMIDE MESYLATE,Small molecule,CHEMBL48582,4.0,['NCT05312632'],MONDO_0005180,Parkinson disease
340,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,4.0,"['NCT00642356', 'NCT00174239']",MONDO_0005180,Parkinson disease
341,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,4.0,['NCT04952194'],MONDO_0005180,Parkinson disease
342,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,4.0,['NCT01515774'],MONDO_0005180,Parkinson disease
343,CHRM2,cholinergic receptor muscarinic 2,ATROPINE,Small molecule,CHEMBL517712,4.0,[],MONDO_0005180,Parkinson disease
344,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,[],MONDO_0005180,Parkinson disease
345,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,4.0,"['NCT01300819', 'NCT01523301', 'NCT01744496', 'NCT00594464', 'NCT01782222', 'NCT01711866', 'NCT03103919']",MONDO_0005180,Parkinson disease
346,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
347,CLCN2,chloride voltage-gated channel 2,LUBIPROSTONE,Small molecule,CHEMBL1201134,4.0,['NCT00908076'],MONDO_0005180,Parkinson disease
348,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
349,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE HYDROCHLORIDE,Small molecule,CHEMBL1569,4.0,[],MONDO_0005180,Parkinson disease
350,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,PROPOFOL,Small molecule,CHEMBL526,4.0,['NCT02256319'],MONDO_0005180,Parkinson disease
351,DRD2,dopamine receptor D2,CABERGOLINE,Small molecule,CHEMBL1201087,4.0,[],MONDO_0005180,Parkinson disease
352,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,4.0,['NCT01313819'],MONDO_0005180,Parkinson disease
353,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
354,CACNA1S,calcium voltage-gated channel subunit alpha1 S,ISRADIPINE,Small molecule,CHEMBL1648,3.0,['NCT02168842'],MONDO_0005180,Parkinson disease
355,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT00599196', 'NCT00505687', 'NCT01631825', 'NCT01646255', 'NCT00243971', 'NCT00243945', 'NCT04571164', 'NCT00594165', 'NCT00501969', 'NCT00594386', 'NCT01628926', 'NCT00244387', 'NCT00522379', 'NCT00474058', 'NCT01723904', 'NCT00593606', 'NCT00242008', 'NCT01646268']",MONDO_0005180,Parkinson disease
356,DRD3,dopamine receptor D3,PARDOPRUNOX,Small molecule,CHEMBL2103832,3.0,"['NCT00134251', 'NCT00332917', 'NCT00269516', 'NCT00335374', 'NCT00407095', 'NCT00406588']",MONDO_0005180,Parkinson disease
357,HTR1A,5-hydroxytryptamine receptor 1A,PARDOPRUNOX,Small molecule,CHEMBL2103832,3.0,"['NCT00269516', 'NCT00335374', 'NCT00407095', 'NCT00134251', 'NCT00406588', 'NCT00332917']",MONDO_0005180,Parkinson disease
358,ADORA2A,adenosine A2a receptor,CAFFEINE,Small molecule,CHEMBL113,3.0,['NCT01738178'],MONDO_0005180,Parkinson disease
359,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,3.0,['NCT02864004'],MONDO_0005180,Parkinson disease
360,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,3.0,"['NCT01063621', 'NCT02006121', 'NCT00200525', 'NCT00145171', 'NCT00955318', 'NCT01058291', 'NCT00142545']",MONDO_0005180,Parkinson disease
361,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT00519532', 'NCT01536015']",MONDO_0005180,Parkinson disease
362,SLC6A2,solute carrier family 6 member 2,VENLAFAXINE HYDROCHLORIDE,Small molecule,CHEMBL1201066,3.0,['NCT00086190'],MONDO_0005180,Parkinson disease
363,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,3.0,"['NCT00240409', 'NCT01007864', 'NCT00275275', 'NCT01191944', 'NCT00466167', 'NCT00577460', 'NCT00274131', 'NCT02172573', 'NCT00601523', 'NCT00335166', 'NCT00558025', 'NCT03329508', 'NCT02177357', 'NCT00479401']",MONDO_0005180,Parkinson disease
364,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
365,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00286897', 'NCT00368108']",MONDO_0005180,Parkinson disease
366,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,3.0,"['NCT00145171', 'NCT01063621', 'NCT01058291', 'NCT00200525', 'NCT02006121', 'NCT00955318', 'NCT00142545']",MONDO_0005180,Parkinson disease
367,HRH3,histamine receptor H3,PITOLISANT,Small molecule,CHEMBL462605,3.0,"['NCT01036139', 'NCT01066442']",MONDO_0005180,Parkinson disease
368,DRD5,dopamine receptor D5,TAVAPADON,Small molecule,CHEMBL3697617,3.0,['NCT04760769'],MONDO_0005180,Parkinson disease
369,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
370,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT04571164', 'NCT01646255', 'NCT01631825', 'NCT01646268', 'NCT00242008', 'NCT00599196', 'NCT00593606', 'NCT00243945', 'NCT00594165', 'NCT00522379', 'NCT00501969', 'NCT00474058', 'NCT00594386', 'NCT00244387', 'NCT01723904', 'NCT00505687', 'NCT01628926', 'NCT00243971']",MONDO_0005180,Parkinson disease
371,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,3.0,"['NCT00203164', 'NCT00203034', 'NCT01268891', 'NCT00203060', 'NCT01479530', 'NCT03329508', 'NCT00203138', 'NCT02337751', 'NCT02337725', 'NCT00203177', 'NCT00203125', 'NCT00256204', 'NCT02337764', 'NCT01155466', 'NCT01556165', 'NCT01736891']",MONDO_0005180,Parkinson disease
372,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
373,DRD2,dopamine receptor D2,SUMANIROLE,Small molecule,CHEMBL419792,3.0,"['NCT00036218', 'NCT00058838']",MONDO_0005180,Parkinson disease
374,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,3.0,"['NCT01058291', 'NCT00955318', 'NCT00145171', 'NCT00200525', 'NCT02469090', 'NCT01039090', 'NCT01504178', 'NCT03391882', 'NCT02006121', 'NCT01063621', 'NCT00142545', 'NCT02542696']",MONDO_0005180,Parkinson disease
375,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,3.0,"['NCT02240030', 'NCT01504178', 'NCT00134966', 'NCT02352363', 'NCT00360568', 'NCT00099268', 'NCT04380142', 'NCT00660673', 'NCT00335153', 'NCT01736176', 'NCT01960842', 'NCT00357994', 'NCT00406588', 'NCT02549092', 'NCT01227655', 'NCT01646255', 'NCT01568073', 'NCT02799381', 'NCT00004733', 'NCT02242487', 'NCT00660387']",MONDO_0005180,Parkinson disease
376,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,3.0,['NCT04006210'],MONDO_0005180,Parkinson disease
377,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,3.0,['NCT04006210'],MONDO_0005180,Parkinson disease
378,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,3.0,['NCT02339064'],MONDO_0005180,Parkinson disease
379,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,3.0,"['NCT00099268', 'NCT01227655', 'NCT02799381', 'NCT00134966', 'NCT01736176', 'NCT02549092', 'NCT01568073', 'NCT00360568', 'NCT00660387', 'NCT00335153', 'NCT01960842', 'NCT00660673', 'NCT00357994']",MONDO_0005180,Parkinson disease
380,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,3.0,['NCT02339064'],MONDO_0005180,Parkinson disease
381,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,['NCT02786667'],MONDO_0005180,Parkinson disease
382,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,['NCT02786667'],MONDO_0005180,Parkinson disease
383,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,3.0,"['NCT00658567', 'NCT01174004', 'NCT00550238', 'NCT00477672']",MONDO_0005180,Parkinson disease
384,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,3.0,['NCT04978597'],MONDO_0005180,Parkinson disease
385,DRD3,dopamine receptor D3,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
386,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00368108', 'NCT00286897']",MONDO_0005180,Parkinson disease
387,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,3.0,"['NCT00955526', 'NCT02610231', 'NCT00199420', 'NCT00203957', 'NCT00957203', 'NCT01968031', 'NCT00199407', 'NCT00199394', 'NCT00199368']",MONDO_0005180,Parkinson disease
388,GLP1R,glucagon like peptide 1 receptor,EXENATIDE,Protein,CHEMBL414357,3.0,['NCT04232969'],MONDO_0005180,Parkinson disease
389,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,3.0,"['NCT00577460', 'NCT02172573', 'NCT00601523', 'NCT00558025', 'NCT00466167', 'NCT02177357', 'NCT00275275', 'NCT00479401', 'NCT01191944', 'NCT00335166', 'NCT00240409', 'NCT00274131', 'NCT01007864', 'NCT03329508']",MONDO_0005180,Parkinson disease
390,OPRD1,opioid receptor delta 1,NALOXONE,Small molecule,CHEMBL80,3.0,['NCT01439100'],MONDO_0005180,Parkinson disease
391,SNAP25,synaptosome associated protein 25,INCOBOTULINUMTOXINA,Unknown,CHEMBL2108035,3.0,['NCT00909883'],MONDO_0005180,Parkinson disease
392,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN TARTRATE,Small molecule,CHEMBL2448613,3.0,"['NCT01174004', 'NCT00477672', 'NCT00550238', 'NCT00658567']",MONDO_0005180,Parkinson disease
393,ADORA2B,adenosine A2b receptor,CAFFEINE,Small molecule,CHEMBL113,3.0,['NCT01738178'],MONDO_0005180,Parkinson disease
394,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT01929317'],MONDO_0005180,Parkinson disease
395,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00360308', 'NCT00505622', 'NCT00360412']",MONDO_0005180,Parkinson disease
396,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
397,ADORA2A,adenosine A2a receptor,PRELADENANT,Small molecule,CHEMBL240624,3.0,"['NCT01227265', 'NCT01155466']",MONDO_0005180,Parkinson disease
398,ADORA2A,adenosine A2a receptor,PRELADENANT,Small molecule,CHEMBL240624,3.0,"['NCT01215227', 'NCT01155479']",MONDO_0005180,Parkinson disease
399,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00360412', 'NCT00505622', 'NCT00360308']",MONDO_0005180,Parkinson disease
400,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT01536015', 'NCT00519532']",MONDO_0005180,Parkinson disease
401,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
402,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00286897', 'NCT00368108']",MONDO_0005180,Parkinson disease
403,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00505622', 'NCT00360412', 'NCT00360308']",MONDO_0005180,Parkinson disease
404,ADRB1,adrenoceptor beta 1,DOPAMINE HYDROCHLORIDE,Small molecule,CHEMBL1557,3.0,['NCT01039090'],MONDO_0005180,Parkinson disease
405,ACHE,acetylcholinesterase (Cartwright blood group),RIVASTIGMINE,Small molecule,CHEMBL636,3.0,['NCT04226248'],MONDO_0005180,Parkinson disease
406,DRD1,dopamine receptor D1,TAVAPADON,Small molecule,CHEMBL3697617,3.0,['NCT04760769'],MONDO_0005180,Parkinson disease
407,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,3.0,"['NCT00139867', 'NCT00139880', 'NCT01039090', 'NCT00465452', 'NCT00038116']",MONDO_0005180,Parkinson disease
408,CACNA1F,calcium voltage-gated channel subunit alpha1 F,ISRADIPINE,Small molecule,CHEMBL1648,3.0,['NCT02168842'],MONDO_0005180,Parkinson disease
409,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT01929317'],MONDO_0005180,Parkinson disease
410,DRD4,dopamine receptor D4,BROMOCRIPTINE,Small molecule,CHEMBL493,3.0,"['NCT02172573', 'NCT00240409']",MONDO_0005180,Parkinson disease
411,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,3.0,"['NCT01227655', 'NCT00357994', 'NCT00099268', 'NCT01568073', 'NCT01736176', 'NCT00335153', 'NCT01960842', 'NCT00660387', 'NCT00360568', 'NCT00660673', 'NCT02549092', 'NCT00134966', 'NCT02799381']",MONDO_0005180,Parkinson disease
412,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
413,SLC6A4,solute carrier family 6 member 4,VENLAFAXINE,Small molecule,CHEMBL637,3.0,['NCT00086190'],MONDO_0005180,Parkinson disease
414,DRD3,dopamine receptor D3,BROMOCRIPTINE,Small molecule,CHEMBL493,3.0,"['NCT02172573', 'NCT00240409']",MONDO_0005180,Parkinson disease
415,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,3.0,"['NCT02605434', 'NCT02615873']",MONDO_0005180,Parkinson disease
416,ACHE,acetylcholinesterase (Cartwright blood group),DONEPEZIL,Small molecule,CHEMBL502,3.0,['NCT00165815'],MONDO_0005180,Parkinson disease
417,MAOB,monoamine oxidase B,RASAGILINE MESYLATE,Small molecule,CHEMBL1201142,3.0,"['NCT00203138', 'NCT00203177', 'NCT02337764', 'NCT00203034', 'NCT01479530', 'NCT00203125', 'NCT00203060', 'NCT00203164', 'NCT02337751', 'NCT02337725', 'NCT00256204']",MONDO_0005180,Parkinson disease
418,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
419,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
420,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,3.0,"['NCT01286935', 'NCT00643045', 'NCT03881371', 'NCT01187966', 'NCT00642889', 'NCT00605683']",MONDO_0005180,Parkinson disease
421,CNR1,cannabinoid receptor 1,NABILONE,Small molecule,CHEMBL2218896,3.0,['NCT03773796'],MONDO_0005180,Parkinson disease
422,DRD5,dopamine receptor D5,TAVAPADON,Small molecule,CHEMBL3697617,3.0,"['NCT04223193', 'NCT04542499', 'NCT04201093']",MONDO_0005180,Parkinson disease
423,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,3.0,['NCT02339064'],MONDO_0005180,Parkinson disease
424,ACHE,acetylcholinesterase (Cartwright blood group),DONEPEZIL,Small molecule,CHEMBL502,3.0,['NCT01014858'],MONDO_0005180,Parkinson disease
425,SLC6A2,solute carrier family 6 member 2,AMPRELOXETINE,Small molecule,CHEMBL4297646,3.0,['NCT03829657'],MONDO_0005180,Parkinson disease
426,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,3.0,['NCT02605434'],MONDO_0005180,Parkinson disease
427,OPRK1,opioid receptor kappa 1,NALOXONE,Small molecule,CHEMBL80,3.0,['NCT01439100'],MONDO_0005180,Parkinson disease
428,SLC6A2,solute carrier family 6 member 2,VENLAFAXINE,Small molecule,CHEMBL637,3.0,['NCT00086190'],MONDO_0005180,Parkinson disease
429,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,3.0,"['NCT00767091', 'NCT00623103']",MONDO_0005180,Parkinson disease
430,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,3.0,"['NCT01063621', 'NCT02542696', 'NCT00200525', 'NCT01039090', 'NCT02469090', 'NCT01058291', 'NCT02006121', 'NCT00955318', 'NCT01504178', 'NCT03391882', 'NCT00142545', 'NCT00145171']",MONDO_0005180,Parkinson disease
431,DRD2,dopamine receptor D2,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,"['NCT01007864', 'NCT00823836']",MONDO_0005180,Parkinson disease
432,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,3.0,"['NCT00650104', 'NCT00363727', 'NCT00036218', 'NCT00823836', 'NCT01628926', 'NCT01536574', 'NCT00275275', 'NCT01154166', 'NCT00381472', 'NCT00331149', 'NCT00632736', 'NCT01007864']",MONDO_0005180,Parkinson disease
433,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,3.0,"['NCT00955318', 'NCT02006121', 'NCT01063621', 'NCT00145171', 'NCT00142545', 'NCT01058291', 'NCT00200525']",MONDO_0005180,Parkinson disease
434,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
435,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,3.0,['NCT00360308'],MONDO_0005180,Parkinson disease
436,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00505622', 'NCT00360412', 'NCT00360308']",MONDO_0005180,Parkinson disease
437,CACNA1C,calcium voltage-gated channel subunit alpha1 C,ISRADIPINE,Small molecule,CHEMBL1648,3.0,['NCT02168842'],MONDO_0005180,Parkinson disease
438,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
439,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT01646255', 'NCT00599196', 'NCT00242008', 'NCT00474058', 'NCT00594386', 'NCT00594165', 'NCT00505687', 'NCT01646268', 'NCT00244387', 'NCT04571164', 'NCT01723904', 'NCT00501969', 'NCT00593606', 'NCT00243945', 'NCT01631825', 'NCT01628926', 'NCT00522379', 'NCT00243971']",MONDO_0005180,Parkinson disease
440,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT01929317'],MONDO_0005180,Parkinson disease
441,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
442,DRD3,dopamine receptor D3,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,3.0,['NCT00275275'],MONDO_0005180,Parkinson disease
443,DRD3,dopamine receptor D3,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,"['NCT01007864', 'NCT00823836']",MONDO_0005180,Parkinson disease
444,SLC6A2,solute carrier family 6 member 2,DULOXETINE,Small molecule,CHEMBL1175,3.0,['NCT01504178'],MONDO_0005180,Parkinson disease
445,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,3.0,['NCT01652534'],MONDO_0005180,Parkinson disease
446,DRD4,dopamine receptor D4,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
447,DRD2,dopamine receptor D2,SUMANIROLE,Small molecule,CHEMBL419792,3.0,['NCT00036205'],MONDO_0005180,Parkinson disease
448,ADORA3,adenosine A3 receptor,CAFFEINE,Small molecule,CHEMBL113,3.0,['NCT01738178'],MONDO_0005180,Parkinson disease
449,ADORA2A,adenosine A2a receptor,TOZADENANT,Small molecule,CHEMBL2105747,3.0,"['NCT03051607', 'NCT02453386']",MONDO_0005180,Parkinson disease
450,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,3.0,['NCT04006210'],MONDO_0005180,Parkinson disease
451,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,['NCT02786667'],MONDO_0005180,Parkinson disease
452,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,3.0,['NCT02864004'],MONDO_0005180,Parkinson disease
453,DRD4,dopamine receptor D4,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,3.0,['NCT00275275'],MONDO_0005180,Parkinson disease
454,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,3.0,"['NCT02615873', 'NCT02605434']",MONDO_0005180,Parkinson disease
455,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
456,CACNA1D,calcium voltage-gated channel subunit alpha1 D,ISRADIPINE,Small molecule,CHEMBL1648,3.0,['NCT02168842'],MONDO_0005180,Parkinson disease
457,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
458,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,3.0,"['NCT01628926', 'NCT00632736', 'NCT00381472', 'NCT00363727', 'NCT01007864', 'NCT00823836', 'NCT00275275', 'NCT00036218', 'NCT01536574', 'NCT01154166', 'NCT00331149', 'NCT00650104']",MONDO_0005180,Parkinson disease
459,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,PERAMPANEL,Small molecule,CHEMBL1214124,3.0,"['NCT00286897', 'NCT00368108']",MONDO_0005180,Parkinson disease
460,SLC6A4,solute carrier family 6 member 4,PAROXETINE,Small molecule,CHEMBL490,3.0,['NCT00086190'],MONDO_0005180,Parkinson disease
461,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,3.0,"['NCT01215227', 'NCT01155479']",MONDO_0005180,Parkinson disease
462,SLC6A4,solute carrier family 6 member 4,DULOXETINE,Small molecule,CHEMBL1175,3.0,['NCT01504178'],MONDO_0005180,Parkinson disease
463,SLC6A4,solute carrier family 6 member 4,VENLAFAXINE HYDROCHLORIDE,Small molecule,CHEMBL1201066,3.0,['NCT00086190'],MONDO_0005180,Parkinson disease
464,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,3.0,"['NCT01536015', 'NCT00519532']",MONDO_0005180,Parkinson disease
465,DRD2,dopamine receptor D2,BROMOCRIPTINE,Small molecule,CHEMBL493,3.0,"['NCT00240409', 'NCT02172573']",MONDO_0005180,Parkinson disease
466,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
467,OPRM1,opioid receptor mu 1,NALOXONE,Small molecule,CHEMBL80,3.0,['NCT01439100'],MONDO_0005180,Parkinson disease
468,DRD4,dopamine receptor D4,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,"['NCT00823836', 'NCT01007864']",MONDO_0005180,Parkinson disease
469,DRD2,dopamine receptor D2,PARDOPRUNOX,Small molecule,CHEMBL2103832,3.0,"['NCT00134251', 'NCT00335374', 'NCT00407095', 'NCT00269516', 'NCT00406588', 'NCT00332917']",MONDO_0005180,Parkinson disease
470,OPRM1,opioid receptor mu 1,OXYCODONE,Small molecule,CHEMBL656,3.0,['NCT01439100'],MONDO_0005180,Parkinson disease
471,DRD2,dopamine receptor D2,ROPINIROLE HYDROCHLORIDE,Small molecule,CHEMBL1200411,3.0,['NCT00260793'],MONDO_0005180,Parkinson disease
472,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,3.0,"['NCT02615873', 'NCT02605434']",MONDO_0005180,Parkinson disease
473,BCHE,butyrylcholinesterase,RIVASTIGMINE,Small molecule,CHEMBL636,3.0,['NCT04226248'],MONDO_0005180,Parkinson disease
474,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,3.0,"['NCT00331149', 'NCT00381472', 'NCT00823836', 'NCT00036218', 'NCT00363727', 'NCT00632736', 'NCT00650104', 'NCT01154166', 'NCT01007864', 'NCT01628926', 'NCT00275275', 'NCT01536574']",MONDO_0005180,Parkinson disease
475,HTR1A,5-hydroxytryptamine receptor 1A,BUSPIRONE,Small molecule,CHEMBL49,3.0,['NCT02617017'],MONDO_0005180,Parkinson disease
476,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,3.0,"['NCT00134966', 'NCT01227655', 'NCT01568073', 'NCT00099268']",MONDO_0005180,Parkinson disease
477,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,3.0,['NCT00199381'],MONDO_0005180,Parkinson disease
478,ADORA1,adenosine A1 receptor,CAFFEINE,Small molecule,CHEMBL113,3.0,['NCT01738178'],MONDO_0005180,Parkinson disease
479,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,3.0,"['NCT00865579', 'NCT01028586']",MONDO_0005180,Parkinson disease
480,DDC,dopa decarboxylase,BENSERAZIDE,Small molecule,CHEMBL1096979,3.0,"['NCT01227655', 'NCT01568073']",MONDO_0005180,Parkinson disease
481,DRD1,dopamine receptor D1,TAVAPADON,Small molecule,CHEMBL3697617,3.0,"['NCT04201093', 'NCT04223193', 'NCT04542499']",MONDO_0005180,Parkinson disease
482,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,3.0,['NCT01851850'],MONDO_0005180,Parkinson disease
483,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,3.0,"['NCT00335166', 'NCT01191944', 'NCT01007864', 'NCT00240409', 'NCT00601523', 'NCT00558025', 'NCT00275275', 'NCT02172573', 'NCT00479401', 'NCT00466167', 'NCT00274131', 'NCT00577460', 'NCT02177357', 'NCT03329508']",MONDO_0005180,Parkinson disease
484,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,MEMANTINE,Small molecule,CHEMBL807,3.0,['NCT03858270'],MONDO_0005180,Parkinson disease
485,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,3.0,"['NCT00142545', 'NCT02542696', 'NCT02006121', 'NCT03391882', 'NCT01058291', 'NCT00145171', 'NCT02469090', 'NCT00955318', 'NCT01504178', 'NCT01063621', 'NCT00200525', 'NCT01039090']",MONDO_0005180,Parkinson disease
486,ACHE,acetylcholinesterase (Cartwright blood group),RIVASTIGMINE,Small molecule,CHEMBL636,3.0,"['NCT00623103', 'NCT00767091']",MONDO_0005180,Parkinson disease
487,DRD2,dopamine receptor D2,PRAMIPEXOLE DIHYDROCHLORIDE,Small molecule,CHEMBL3182733,3.0,['NCT00275275'],MONDO_0005180,Parkinson disease
488,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,3.0,['NCT02864004'],MONDO_0005180,Parkinson disease
489,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00758368', 'NCT00472355']",MONDO_0005180,Parkinson disease
490,NDUFB8,NADH:ubiquinone oxidoreductase subunit B8,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
491,ADORA2A,adenosine A2a receptor,VIPADENANT,Small molecule,CHEMBL447664,2.0,"['NCT00438607', 'NCT00442780']",MONDO_0005180,Parkinson disease
492,SLC6A3,solute carrier family 6 member 3,METHYLPHENIDATE,Small molecule,CHEMBL796,2.0,['NCT05669170'],MONDO_0005180,Parkinson disease
493,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
494,GLP1R,glucagon like peptide 1 receptor,SEMAGLUTIDE,Protein,CHEMBL2108724,2.0,['NCT03659682'],MONDO_0005180,Parkinson disease
495,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,NICOTINE,Small molecule,CHEMBL3,2.0,"['NCT00873392', 'NCT03865121']",MONDO_0005180,Parkinson disease
496,UGCG,UDP-glucose ceramide glucosyltransferase,VENGLUSTAT,Small molecule,CHEMBL4297611,2.0,['NCT02906020'],MONDO_0005180,Parkinson disease
497,SCN4A,sodium voltage-gated channel alpha subunit 4,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
498,DRD2,dopamine receptor D2,SARIZOTAN HYDROCHLORIDE,Small molecule,CHEMBL2146110,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
499,ADRA1D,adrenoceptor alpha 1D,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
500,DRD1,dopamine receptor D1,TAVAPADON,Small molecule,CHEMBL3697617,2.0,"['NCT03185481', 'NCT02687542', 'NCT02847650']",MONDO_0005180,Parkinson disease
501,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,2.0,['NCT04164758'],MONDO_0005180,Parkinson disease
502,GRM4,glutamate metabotropic receptor 4,FOLIGLURAX,Small molecule,CHEMBL4089083,2.0,['NCT03331848'],MONDO_0005180,Parkinson disease
503,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,2.0,['NCT00562198'],MONDO_0005180,Parkinson disease
504,BCR,BCR activator of RhoGEF and GTPase,RADOTINIB,Small molecule,CHEMBL4297524,2.0,['NCT04691661'],MONDO_0005180,Parkinson disease
505,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,2.0,['NCT03301272'],MONDO_0005180,Parkinson disease
506,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
507,CHRM3,cholinergic receptor muscarinic 3,IPRATROPIUM BROMIDE,Small molecule,CHEMBL2134724,2.0,['NCT00296946'],MONDO_0005180,Parkinson disease
508,DRD2,dopamine receptor D2,APLINDORE,Small molecule,CHEMBL2110659,2.0,['NCT00809302'],MONDO_0005180,Parkinson disease
509,ACHE,acetylcholinesterase (Cartwright blood group),PYRIDOSTIGMINE,Small molecule,CHEMBL1115,2.0,['NCT01993680'],MONDO_0005180,Parkinson disease
510,HTR1A,5-hydroxytryptamine receptor 1A,SARIZOTAN HYDROCHLORIDE,Small molecule,CHEMBL2146110,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
511,ADRA2C,adrenoceptor alpha 2C,FIPAMEZOLE,Small molecule,CHEMBL1255582,2.0,['NCT00559871'],MONDO_0005180,Parkinson disease
512,NDUFS5,NADH:ubiquinone oxidoreductase subunit S5,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
513,NDUFA7,NADH:ubiquinone oxidoreductase subunit A7,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
514,NDUFB10,NADH:ubiquinone oxidoreductase subunit B10,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
515,MT-ND3,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
516,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,"['NCT01631812', 'NCT01628965', 'NCT01634243', 'NCT01628848', 'NCT00537485', 'NCT00296192']",MONDO_0005180,Parkinson disease
517,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
518,NDUFV1,NADH:ubiquinone oxidoreductase core subunit V1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
519,DRD2,dopamine receptor D2,SARIZOTAN,Small molecule,CHEMBL220808,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
520,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
521,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",VODOBATINIB,Small molecule,CHEMBL4130229,2.0,['NCT03655236'],MONDO_0005180,Parkinson disease
522,SCN10A,sodium voltage-gated channel alpha subunit 10,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
523,CSF3R,colony stimulating factor 3 receptor,FILGRASTIM,Protein,CHEMBL1201567,2.0,['NCT01227681'],MONDO_0005180,Parkinson disease
524,COMT,catechol-O-methyltransferase,NEBICAPONE,Small molecule,CHEMBL160038,2.0,['NCT03103399'],MONDO_0005180,Parkinson disease
525,SLC6A4,solute carrier family 6 member 4,DULOXETINE,Small molecule,CHEMBL1175,2.0,['NCT02857244'],MONDO_0005180,Parkinson disease
526,HTR1A,5-hydroxytryptamine receptor 1A,PARDOPRUNOX,Small molecule,CHEMBL2103832,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
527,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,2.0,['NCT03576638'],MONDO_0005180,Parkinson disease
528,NDUFB11,NADH:ubiquinone oxidoreductase subunit B11,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
529,SCN8A,sodium voltage-gated channel alpha subunit 8,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
530,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT02347059'],MONDO_0005180,Parkinson disease
531,NDUFAB1,NADH:ubiquinone oxidoreductase subunit AB1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
532,GLP1R,glucagon like peptide 1 receptor,EXENATIDE,Protein,CHEMBL414357,2.0,['NCT01971242'],MONDO_0005180,Parkinson disease
533,NDUFV3,NADH:ubiquinone oxidoreductase subunit V3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
534,SCN11A,sodium voltage-gated channel alpha subunit 11,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
535,ESR2,estrogen receptor 2,"ESTROGENS, CONJUGATED",Small molecule,CHEMBL1201649,2.0,['NCT00234676'],MONDO_0005180,Parkinson disease
536,ADRA2B,adrenoceptor alpha 2B,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
537,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,2.0,"['NCT00460148', 'NCT00434304']",MONDO_0005180,Parkinson disease
538,NDUFA13,NADH:ubiquinone oxidoreductase subunit A13,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
539,DRD2,dopamine receptor D2,DOMPERIDONE,Small molecule,CHEMBL219916,2.0,['NCT00006077'],MONDO_0005180,Parkinson disease
540,ACHE,acetylcholinesterase (Cartwright blood group),DONEPEZIL,Small molecule,CHEMBL502,2.0,"['NCT02450786', 'NCT02415062']",MONDO_0005180,Parkinson disease
541,NDUFB4,NADH:ubiquinone oxidoreductase subunit B4,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
542,ESR1,estrogen receptor 1,"ESTROGENS, CONJUGATED",Small molecule,CHEMBL1201649,2.0,['NCT00234676'],MONDO_0005180,Parkinson disease
543,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT00165789', 'NCT01172379']",MONDO_0005180,Parkinson disease
544,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,"['NCT00560508', 'NCT01968460', 'NCT03845387']",MONDO_0005180,Parkinson disease
545,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
546,ADORA1,adenosine A1 receptor,CAFFEINE,Small molecule,CHEMBL113,2.0,"['NCT01190735', 'NCT00459420']",MONDO_0005180,Parkinson disease
547,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,2.0,"['NCT02577523', 'NCT02641054', 'NCT00009048', 'NCT01777555', 'NCT00089622', 'NCT01479127', 'NCT01883505', 'NCT01617135', 'NCT00558337', 'NCT02271503', 'NCT01568034', 'NCT00918177', 'NCT00745277', 'NCT00108667', 'NCT00086294', 'NCT02764125', 'NCT01283594', 'NCT02601586', 'NCT03000569', 'NCT03541356', 'NCT00253084', 'NCT00040209', 'NCT01515410', 'NCT00279825', 'NCT04778176', 'NCT00006337', 'NCT00006077', 'NCT03103399', 'NCT03007888', 'NCT01171313', 'NCT00013624', 'NCT01568047', 'NCT00076674']",MONDO_0005180,Parkinson disease
548,ADRA2C,adrenoceptor alpha 2C,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
549,ADRA2B,adrenoceptor alpha 2B,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
550,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
551,MT-ND1,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
552,NDUFA8,NADH:ubiquinone oxidoreductase subunit A8,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
553,MTNR1A,melatonin receptor 1A,MELATONIN,Small molecule,CHEMBL45,2.0,['NCT04287543'],MONDO_0005180,Parkinson disease
554,GPD2,glycerol-3-phosphate dehydrogenase 2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
555,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
556,BCR,BCR activator of RhoGEF and GTPase,NILOTINIB,Small molecule,CHEMBL255863,2.0,['NCT02954978'],MONDO_0005180,Parkinson disease
557,NDUFA10,NADH:ubiquinone oxidoreductase subunit A10,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
558,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,2.0,"['NCT05781711', 'NCT05036473']",MONDO_0005180,Parkinson disease
559,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,VARENICLINE,Small molecule,CHEMBL1396,2.0,"['NCT02933372', 'NCT01341080', 'NCT04403399']",MONDO_0005180,Parkinson disease
560,ADRA2A,adrenoceptor alpha 2A,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
561,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00758368', 'NCT00472355']",MONDO_0005180,Parkinson disease
562,SCN11A,sodium voltage-gated channel alpha subunit 11,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
563,NDUFB2,NADH:ubiquinone oxidoreductase subunit B2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
564,MT-ND6,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
565,ADORA2B,adenosine A2b receptor,CAFFEINE,Small molecule,CHEMBL113,2.0,"['NCT00459420', 'NCT01190735']",MONDO_0005180,Parkinson disease
566,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,2.0,"['NCT02347059', 'NCT03576638']",MONDO_0005180,Parkinson disease
567,MAP3K11,mitogen-activated protein kinase kinase kinase 11,CEP-1347,Small molecule,CHEMBL290352,2.0,['NCT00040404'],MONDO_0005180,Parkinson disease
568,SCN5A,sodium voltage-gated channel alpha subunit 5,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
569,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,ZOLPIDEM,Small molecule,CHEMBL911,2.0,['NCT03621046'],MONDO_0005180,Parkinson disease
570,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,['NCT00451633'],MONDO_0005180,Parkinson disease
571,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,NICOTINE,Small molecule,CHEMBL3,2.0,"['NCT03865121', 'NCT00873392']",MONDO_0005180,Parkinson disease
572,ADORA2A,adenosine A2a receptor,CAFFEINE,Small molecule,CHEMBL113,2.0,"['NCT01190735', 'NCT00459420']",MONDO_0005180,Parkinson disease
573,DRD3,dopamine receptor D3,SARIZOTAN,Small molecule,CHEMBL220808,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
574,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,LOVASTATIN,Small molecule,CHEMBL503,2.0,['NCT03242499'],MONDO_0005180,Parkinson disease
575,DRD2,dopamine receptor D2,APLINDORE,Small molecule,CHEMBL2110659,2.0,['NCT00623324'],MONDO_0005180,Parkinson disease
576,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
577,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
578,BCR,BCR activator of RhoGEF and GTPase,NILOTINIB,Small molecule,CHEMBL255863,2.0,['NCT03205488'],MONDO_0005180,Parkinson disease
579,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
580,SCN7A,sodium voltage-gated channel alpha subunit 7,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
581,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT01634360', 'NCT00427011', 'NCT00566462']",MONDO_0005180,Parkinson disease
582,GABRD,gamma-aminobutyric acid type A receptor subunit delta,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
583,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
584,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
585,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
586,DRD3,dopamine receptor D3,SARIZOTAN HYDROCHLORIDE,Small molecule,CHEMBL2146110,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
587,NR3C2,nuclear receptor subfamily 3 group C member 2,FLUDROCORTISONE ACETATE,Small molecule,CHEMBL1201010,2.0,['NCT01993680'],MONDO_0005180,Parkinson disease
588,NDUFS3,NADH:ubiquinone oxidoreductase core subunit S3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
589,CHRM3,cholinergic receptor muscarinic 3,TROPICAMIDE,Small molecule,CHEMBL1200604,2.0,['NCT00761137'],MONDO_0005180,Parkinson disease
590,ADRB2,adrenoceptor beta 2,CLENBUTEROL,Small molecule,CHEMBL49080,2.0,['NCT04935762'],MONDO_0005180,Parkinson disease
591,SCN7A,sodium voltage-gated channel alpha subunit 7,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
592,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,['NCT00451633'],MONDO_0005180,Parkinson disease
593,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
594,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,2.0,"['NCT02337738', 'NCT01968460']",MONDO_0005180,Parkinson disease
595,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
596,SNAP25,synaptosome associated protein 25,INCOBOTULINUMTOXINA,Unknown,CHEMBL2108035,2.0,['NCT02419313'],MONDO_0005180,Parkinson disease
597,NDUFA11,NADH:ubiquinone oxidoreductase subunit A11,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
598,ADRA1B,adrenoceptor alpha 1B,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
599,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT04879134'],MONDO_0005180,Parkinson disease
600,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT02347059'],MONDO_0005180,Parkinson disease
601,SCN5A,sodium voltage-gated channel alpha subunit 5,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
602,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN TARTRATE,Small molecule,CHEMBL2448613,2.0,"['NCT00086294', 'NCT01518309']",MONDO_0005180,Parkinson disease
603,NQO1,NAD(P)H quinone dehydrogenase 1,VATIQUINONE,Small molecule,CHEMBL1812161,2.0,['NCT01923584'],MONDO_0005180,Parkinson disease
604,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
605,NDUFS2,NADH:ubiquinone oxidoreductase core subunit S2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
606,DRD5,dopamine receptor D5,TAVAPADON,Small molecule,CHEMBL3697617,2.0,"['NCT03185481', 'NCT02847650', 'NCT02687542']",MONDO_0005180,Parkinson disease
607,MMP8,matrix metallopeptidase 8,DOXYCYCLINE ANHYDROUS,Small molecule,CHEMBL1433,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
608,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,TRAXOPRODIL,Small molecule,CHEMBL17350,2.0,['NCT00163085'],MONDO_0005180,Parkinson disease
609,MAP3K9,mitogen-activated protein kinase kinase kinase 9,CEP-1347,Small molecule,CHEMBL290352,2.0,['NCT00040404'],MONDO_0005180,Parkinson disease
610,NDUFS6,NADH:ubiquinone oxidoreductase subunit S6,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
611,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,2.0,['NCT03576638'],MONDO_0005180,Parkinson disease
612,ADRA2C,adrenoceptor alpha 2C,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
613,SNCA,synuclein alpha,CINPANEMAB,Antibody,CHEMBL3833330,2.0,['NCT03318523'],MONDO_0005180,Parkinson disease
614,SCN9A,sodium voltage-gated channel alpha subunit 9,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
615,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",NILOTINIB HYDROCHLORIDE MONOHYDRATE,Small molecule,CHEMBL1201740,2.0,['NCT02954978'],MONDO_0005180,Parkinson disease
616,INSR,insulin receptor,INSULIN,Protein,CHEMBL1201631,2.0,"['NCT04251585', 'NCT04687878']",MONDO_0005180,Parkinson disease
617,NDUFS8,NADH:ubiquinone oxidoreductase core subunit S8,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
618,DRD4,dopamine receptor D4,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,2.0,"['NCT00200512', 'NCT03292016', 'NCT00610103']",MONDO_0005180,Parkinson disease
619,ACHE,acetylcholinesterase (Cartwright blood group),DONEPEZIL,Small molecule,CHEMBL502,2.0,['NCT02206620'],MONDO_0005180,Parkinson disease
620,GABBR2,gamma-aminobutyric acid type B receptor subunit 2,SODIUM OXYBATE,Small molecule,CHEMBL1200682,2.0,"['NCT00641186', 'NCT02111122']",MONDO_0005180,Parkinson disease
621,GLP1R,glucagon like peptide 1 receptor,EXENATIDE,Protein,CHEMBL414357,2.0,['NCT04305002'],MONDO_0005180,Parkinson disease
622,SCN1A,sodium voltage-gated channel alpha subunit 1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
623,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
624,SCN3A,sodium voltage-gated channel alpha subunit 3,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
625,MMP8,matrix metallopeptidase 8,DOXYCYCLINE,Small molecule,CHEMBL1200699,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
626,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
627,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,2.0,['NCT01351168'],MONDO_0005180,Parkinson disease
628,NDUFB3,NADH:ubiquinone oxidoreductase subunit B3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
629,OPRM1,opioid receptor mu 1,OXYCODONE,Small molecule,CHEMBL656,2.0,['NCT02601586'],MONDO_0005180,Parkinson disease
630,SLC6A2,solute carrier family 6 member 2,TESOFENSINE,Small molecule,CHEMBL3989690,2.0,"['NCT00148486', 'NCT00148512']",MONDO_0005180,Parkinson disease
631,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00200512', 'NCT03292016', 'NCT00040209', 'NCT00610103', 'NCT01683292', 'NCT00346827', 'NCT01693081', 'NCT03187301', 'NCT02228590']",MONDO_0005180,Parkinson disease
632,ADRB2,adrenoceptor beta 2,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
633,MMP1,matrix metallopeptidase 1,DOXYCYCLINE ANHYDROUS,Small molecule,CHEMBL1433,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
634,NDUFAF1,NADH:ubiquinone oxidoreductase complex assembly factor 1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
635,HTR1A,5-hydroxytryptamine receptor 1A,SARIZOTAN,Small molecule,CHEMBL220808,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
636,CA2,carbonic anhydrase 2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
637,GLP1R,glucagon like peptide 1 receptor,EXENATIDE,Protein,CHEMBL414357,2.0,['NCT01174810'],MONDO_0005180,Parkinson disease
638,DRD2,dopamine receptor D2,QUETIAPINE,Small molecule,CHEMBL716,2.0,['NCT04164758'],MONDO_0005180,Parkinson disease
639,CNR1,cannabinoid receptor 1,NABILONE,Small molecule,CHEMBL2218896,2.0,['NCT03769896'],MONDO_0005180,Parkinson disease
640,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
641,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
642,ADORA2A,adenosine A2a receptor,PRELADENANT,Small molecule,CHEMBL240624,2.0,['NCT01294800'],MONDO_0005180,Parkinson disease
643,ADRB1,adrenoceptor beta 1,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
644,OPRL1,opioid related nociceptin receptor 1,LY-2940094,Small molecule,CHEMBL3304244,2.0,['NCT03608371'],MONDO_0005180,Parkinson disease
645,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,"['NCT03845387', 'NCT00560508', 'NCT01968460']",MONDO_0005180,Parkinson disease
646,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
647,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,ZOLPIDEM,Small molecule,CHEMBL911,2.0,['NCT01351168'],MONDO_0005180,Parkinson disease
648,SLC6A3,solute carrier family 6 member 3,METHYLPHENIDATE,Small molecule,CHEMBL796,2.0,['NCT00359723'],MONDO_0005180,Parkinson disease
649,SCN2A,sodium voltage-gated channel alpha subunit 2,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
650,NDUFB9,NADH:ubiquinone oxidoreductase subunit B9,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
651,PDE5A,phosphodiesterase 5A,SILDENAFIL,Small molecule,CHEMBL192,2.0,['NCT02162979'],MONDO_0005180,Parkinson disease
652,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
653,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,"['NCT03845387', 'NCT01968460', 'NCT00560508']",MONDO_0005180,Parkinson disease
654,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,2.0,"['NCT05036473', 'NCT05781711']",MONDO_0005180,Parkinson disease
655,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
656,GABRP,gamma-aminobutyric acid type A receptor subunit pi,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
657,NDUFB5,NADH:ubiquinone oxidoreductase subunit B5,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
658,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",NILOTINIB,Small molecule,CHEMBL255863,2.0,['NCT02954978'],MONDO_0005180,Parkinson disease
659,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
660,VDR,vitamin D receptor,CHOLECALCIFEROL,Small molecule,CHEMBL1042,2.0,"['NCT01119131', 'NCT00907972']",MONDO_0005180,Parkinson disease
661,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,2.0,"['NCT00434304', 'NCT00460148']",MONDO_0005180,Parkinson disease
662,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,2.0,['NCT03947216'],MONDO_0005180,Parkinson disease
663,SV2A,synaptic vesicle glycoprotein 2A,LEVETIRACETAM,Small molecule,CHEMBL1286,2.0,['NCT00160576'],MONDO_0005180,Parkinson disease
664,HTR2C,5-hydroxytryptamine receptor 2C,QUETIAPINE,Small molecule,CHEMBL716,2.0,['NCT04164758'],MONDO_0005180,Parkinson disease
665,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
666,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,NICOTINE,Small molecule,CHEMBL3,2.0,['NCT01560754'],MONDO_0005180,Parkinson disease
667,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,['NCT02103465'],MONDO_0005180,Parkinson disease
668,NDUFS1,NADH:ubiquinone oxidoreductase core subunit S1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
669,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,TALAMPANEL,Small molecule,CHEMBL61872,2.0,"['NCT00108667', 'NCT00004576']",MONDO_0005180,Parkinson disease
670,CACNA1C,calcium voltage-gated channel subunit alpha1 C,ISRADIPINE,Small molecule,CHEMBL1648,2.0,"['NCT00909545', 'NCT00753636']",MONDO_0005180,Parkinson disease
671,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
672,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
673,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,2.0,['NCT00562198'],MONDO_0005180,Parkinson disease
674,SCN3A,sodium voltage-gated channel alpha subunit 3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
675,MT-ND5,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
676,NDUFC1,NADH:ubiquinone oxidoreductase subunit C1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
677,NDUFA1,NADH:ubiquinone oxidoreductase subunit A1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
678,ADRB1,adrenoceptor beta 1,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
679,ADRB2,adrenoceptor beta 2,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
680,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT02347059'],MONDO_0005180,Parkinson disease
681,DRD4,dopamine receptor D4,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT02702076'],MONDO_0005180,Parkinson disease
682,DRD3,dopamine receptor D3,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,2.0,"['NCT03292016', 'NCT00610103', 'NCT00200512']",MONDO_0005180,Parkinson disease
683,ADRA2A,adrenoceptor alpha 2A,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
684,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT00165789', 'NCT01172379']",MONDO_0005180,Parkinson disease
685,NDUFB1,NADH:ubiquinone oxidoreductase subunit B1,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
686,MTNR1B,melatonin receptor 1B,MELATONIN,Small molecule,CHEMBL45,2.0,['NCT04287543'],MONDO_0005180,Parkinson disease
687,GRM5,glutamate metabotropic receptor 5,DIPRAGLURANT,Small molecule,CHEMBL2346738,2.0,['NCT01336088'],MONDO_0005180,Parkinson disease
688,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,2.0,"['NCT02834507', 'NCT00200447', 'NCT00237263', 'NCT01568034', 'NCT01568047', 'NCT03103399']",MONDO_0005180,Parkinson disease
689,PPARG,peroxisome proliferator activated receptor gamma,PIOGLITAZONE,Small molecule,CHEMBL595,2.0,['NCT01280123'],MONDO_0005180,Parkinson disease
690,MMP13,matrix metallopeptidase 13,DOXYCYCLINE ANHYDROUS,Small molecule,CHEMBL1433,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
691,NDUFA2,NADH:ubiquinone oxidoreductase subunit A2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
692,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
693,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,ZOLPIDEM,Small molecule,CHEMBL911,2.0,['NCT01351168'],MONDO_0005180,Parkinson disease
694,ADORA3,adenosine A3 receptor,CAFFEINE,Small molecule,CHEMBL113,2.0,"['NCT00459420', 'NCT01190735']",MONDO_0005180,Parkinson disease
695,NDUFB6,NADH:ubiquinone oxidoreductase subunit B6,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
696,SLC6A2,solute carrier family 6 member 2,DULOXETINE,Small molecule,CHEMBL1175,2.0,['NCT02857244'],MONDO_0005180,Parkinson disease
697,NDUFS7,NADH:ubiquinone oxidoreductase core subunit S7,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
698,SIGMAR1,sigma non-opioid intracellular receptor 1,DEXTROMETHORPHAN,Small molecule,CHEMBL52440,2.0,['NCT00001365'],MONDO_0005180,Parkinson disease
699,ADRA1A,adrenoceptor alpha 1A,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
700,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
701,DRD2,dopamine receptor D2,APOMORPHINE HYDROCHLORIDE,Small molecule,CHEMBL1616,2.0,"['NCT00200512', 'NCT03292016', 'NCT00610103']",MONDO_0005180,Parkinson disease
702,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT00427011', 'NCT01634360', 'NCT00566462']",MONDO_0005180,Parkinson disease
703,GRIK5,glutamate ionotropic receptor kainate type subunit 5,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
704,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
705,SLC6A3,solute carrier family 6 member 3,TESOFENSINE,Small molecule,CHEMBL3989690,2.0,"['NCT00148486', 'NCT00148512']",MONDO_0005180,Parkinson disease
706,DRD3,dopamine receptor D3,MESDOPETAM,Small molecule,CHEMBL4594447,2.0,"['NCT03368170', 'NCT04435431']",MONDO_0005180,Parkinson disease
707,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
708,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",RADOTINIB,Small molecule,CHEMBL4297524,2.0,['NCT04691661'],MONDO_0005180,Parkinson disease
709,ACHE,acetylcholinesterase (Cartwright blood group),PYRIDOSTIGMINE BROMIDE,Small molecule,CHEMBL812,2.0,['NCT01993680'],MONDO_0005180,Parkinson disease
710,MAP3K12,mitogen-activated protein kinase kinase kinase 12,CEP-1347,Small molecule,CHEMBL290352,2.0,['NCT00040404'],MONDO_0005180,Parkinson disease
711,INSR,insulin receptor,INSULIN,Protein,CHEMBL1201631,2.0,['NCT02064166'],MONDO_0005180,Parkinson disease
712,DRD2,dopamine receptor D2,PARDOPRUNOX,Small molecule,CHEMBL2103832,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
713,GLP1R,glucagon like peptide 1 receptor,LIXISENATIDE,Protein,CHEMBL2108336,2.0,['NCT03439943'],MONDO_0005180,Parkinson disease
714,NDUFB7,NADH:ubiquinone oxidoreductase subunit B7,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
715,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
716,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
717,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,DEXTROMETHORPHAN,Small molecule,CHEMBL52440,2.0,['NCT00001365'],MONDO_0005180,Parkinson disease
718,HTR1A,5-hydroxytryptamine receptor 1A,PICLOZOTAN,Small molecule,CHEMBL345237,2.0,['NCT00623363'],MONDO_0005180,Parkinson disease
719,GLP1R,glucagon like peptide 1 receptor,LIRAGLUTIDE,Protein,CHEMBL4084119,2.0,['NCT02953665'],MONDO_0005180,Parkinson disease
720,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
721,NDUFA6,NADH:ubiquinone oxidoreductase subunit A6,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
722,ACHE,acetylcholinesterase (Cartwright blood group),DONEPEZIL,Small molecule,CHEMBL502,2.0,['NCT02857244'],MONDO_0005180,Parkinson disease
723,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
724,SCN1A,sodium voltage-gated channel alpha subunit 1,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
725,NDUFAF4,NADH:ubiquinone oxidoreductase complex assembly factor 4,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
726,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,2.0,['NCT02668497'],MONDO_0005180,Parkinson disease
727,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT01634360', 'NCT00566462', 'NCT00427011']",MONDO_0005180,Parkinson disease
728,GRIK2,glutamate ionotropic receptor kainate type subunit 2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
729,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
730,DRD3,dopamine receptor D3,PARDOPRUNOX,Small molecule,CHEMBL2103832,2.0,['NCT00903838'],MONDO_0005180,Parkinson disease
731,NDUFA3,NADH:ubiquinone oxidoreductase subunit A3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
732,NDUFAF3,NADH:ubiquinone oxidoreductase complex assembly factor 3,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
733,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
734,GRIK3,glutamate ionotropic receptor kainate type subunit 3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
735,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,2.0,['NCT01264861'],MONDO_0005180,Parkinson disease
736,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,"['NCT01631812', 'NCT01634243', 'NCT00537485', 'NCT01628965', 'NCT00296192', 'NCT01628848']",MONDO_0005180,Parkinson disease
737,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT04879134'],MONDO_0005180,Parkinson disease
738,NDUFA4,NDUFA4 mitochondrial complex associated,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
739,GABRD,gamma-aminobutyric acid type A receptor subunit delta,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
740,CNR1,cannabinoid receptor 1,CANNABIDIOL,Small molecule,CHEMBL190461,2.0,"['NCT02818777', 'NCT03582137']",MONDO_0005180,Parkinson disease
741,ADRB3,adrenoceptor beta 3,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
742,HTR2A,5-hydroxytryptamine receptor 2A,PIMAVANSERIN,Small molecule,CHEMBL2111101,2.0,"['NCT01518309', 'NCT00086294']",MONDO_0005180,Parkinson disease
743,NDUFA5,NADH:ubiquinone oxidoreductase subunit A5,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
744,MMP7,matrix metallopeptidase 7,DOXYCYCLINE ANHYDROUS,Small molecule,CHEMBL1433,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
745,MT-ND2,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
746,GABRP,gamma-aminobutyric acid type A receptor subunit pi,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
747,ADORA2A,adenosine A2a receptor,VIPADENANT,Small molecule,CHEMBL447664,2.0,['NCT00451815'],MONDO_0005180,Parkinson disease
748,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,"['NCT01628965', 'NCT00537485', 'NCT01631812', 'NCT00296192', 'NCT01634243', 'NCT01628848']",MONDO_0005180,Parkinson disease
749,GRIK1,glutamate ionotropic receptor kainate type subunit 1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
750,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,2.0,"['NCT00955045', 'NCT00006337', 'NCT00455507', 'NCT00250393', 'NCT00456794', 'NCT00456586', 'NCT00199355']",MONDO_0005180,Parkinson disease
751,SCN8A,sodium voltage-gated channel alpha subunit 8,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
752,ADRA2B,adrenoceptor alpha 2B,FIPAMEZOLE,Small molecule,CHEMBL1255582,2.0,['NCT00559871'],MONDO_0005180,Parkinson disease
753,CHRM1,cholinergic receptor muscarinic 1,TAK-071,Small molecule,CHEMBL4594351,2.0,['NCT04334317'],MONDO_0005180,Parkinson disease
754,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,['NCT02103465'],MONDO_0005180,Parkinson disease
755,MAOB,monoamine oxidase B,RASAGILINE MESYLATE,Small molecule,CHEMBL1201142,2.0,['NCT02337738'],MONDO_0005180,Parkinson disease
756,SLC6A3,solute carrier family 6 member 3,MODAFINIL,Small molecule,CHEMBL1373,2.0,['NCT02857244'],MONDO_0005180,Parkinson disease
757,NDUFA9,NADH:ubiquinone oxidoreductase subunit A9,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
758,SLC6A2,solute carrier family 6 member 2,METHYLPHENIDATE,Small molecule,CHEMBL796,2.0,['NCT05669170'],MONDO_0005180,Parkinson disease
759,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,TALAMPANEL,Small molecule,CHEMBL61872,2.0,"['NCT00108667', 'NCT00004576']",MONDO_0005180,Parkinson disease
760,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,NICOTINE,Small molecule,CHEMBL3,2.0,['NCT01560754'],MONDO_0005180,Parkinson disease
761,SNCA,synuclein alpha,PRASINEZUMAB,Antibody,CHEMBL4298077,2.0,['NCT03100149'],MONDO_0005180,Parkinson disease
762,GABBR1,gamma-aminobutyric acid type B receptor subunit 1,OXYBATE,Small molecule,CHEMBL1342,2.0,"['NCT02111122', 'NCT00641186']",MONDO_0005180,Parkinson disease
763,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,2.0,"['NCT01617135', 'NCT01399905', 'NCT03103399', 'NCT02271503', 'NCT00253084', 'NCT00279825', 'NCT02577523', 'NCT01568034', 'NCT03007888', 'NCT01883505', 'NCT01479127', 'NCT01171313', 'NCT00200447', 'NCT04778176', 'NCT00558337', 'NCT00745277', 'NCT01296464', 'NCT03541356', 'NCT01766258', 'NCT00918177', 'NCT01515410', 'NCT01568047']",MONDO_0005180,Parkinson disease
764,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,2.0,"['NCT05781711', 'NCT05036473']",MONDO_0005180,Parkinson disease
765,DRD4,dopamine receptor D4,SARIZOTAN,Small molecule,CHEMBL220808,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
766,NDUFA4L2,NDUFA4 mitochondrial complex associated like 2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
767,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
768,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
769,DRD2,dopamine receptor D2,PRIDOPIDINE,Small molecule,CHEMBL596802,2.0,['NCT03922711'],MONDO_0005180,Parkinson disease
770,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,2.0,['NCT02789020'],MONDO_0005180,Parkinson disease
771,BCR,BCR activator of RhoGEF and GTPase,VODOBATINIB,Small molecule,CHEMBL4130229,2.0,['NCT03655236'],MONDO_0005180,Parkinson disease
772,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,['NCT00451633'],MONDO_0005180,Parkinson disease
773,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00610103', 'NCT03187301', 'NCT00040209', 'NCT00346827', 'NCT03292016', 'NCT02228590', 'NCT01693081', 'NCT01683292', 'NCT00200512']",MONDO_0005180,Parkinson disease
774,SCN9A,sodium voltage-gated channel alpha subunit 9,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
775,SNCA,synuclein alpha,PRASINEZUMAB,Antibody,CHEMBL4298077,2.0,['NCT04777331'],MONDO_0005180,Parkinson disease
776,NDUFV2,NADH:ubiquinone oxidoreductase core subunit V2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
777,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
778,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,2.0,['NCT01113320'],MONDO_0005180,Parkinson disease
779,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,2.0,['NCT00562198'],MONDO_0005180,Parkinson disease
780,ADRA1D,adrenoceptor alpha 1D,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
781,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
782,SCN2A,sodium voltage-gated channel alpha subunit 2,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
783,MAP3K13,mitogen-activated protein kinase kinase kinase 13,CEP-1347,Small molecule,CHEMBL290352,2.0,['NCT00040404'],MONDO_0005180,Parkinson disease
784,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,VARENICLINE,Small molecule,CHEMBL1396,2.0,"['NCT01341080', 'NCT04403399', 'NCT02933372']",MONDO_0005180,Parkinson disease
785,SLC6A3,solute carrier family 6 member 3,MODAFINIL,Small molecule,CHEMBL1373,2.0,['NCT03083132'],MONDO_0005180,Parkinson disease
786,MT-ND4,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
787,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,2.0,"['NCT01515410', 'NCT02834507']",MONDO_0005180,Parkinson disease
788,SCN10A,sodium voltage-gated channel alpha subunit 10,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
789,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
790,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT01634360', 'NCT00566462', 'NCT00427011']",MONDO_0005180,Parkinson disease
791,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,SIMVASTATIN,Small molecule,CHEMBL1064,2.0,['NCT02787590'],MONDO_0005180,Parkinson disease
792,MAP3K10,mitogen-activated protein kinase kinase kinase 10,CEP-1347,Small molecule,CHEMBL290352,2.0,['NCT00040404'],MONDO_0005180,Parkinson disease
793,SLC6A4,solute carrier family 6 member 4,CITALOPRAM,Small molecule,CHEMBL549,2.0,['NCT04497168'],MONDO_0005180,Parkinson disease
794,MPO,myeloperoxidase,VERDIPERSTAT,Small molecule,CHEMBL4297594,2.0,"['NCT01527695', 'NCT01603069']",MONDO_0005180,Parkinson disease
795,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
796,MMP1,matrix metallopeptidase 1,DOXYCYCLINE,Small molecule,CHEMBL1200699,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
797,CACNA1D,calcium voltage-gated channel subunit alpha1 D,ISRADIPINE,Small molecule,CHEMBL1648,2.0,"['NCT00753636', 'NCT00909545']",MONDO_0005180,Parkinson disease
798,CACNA1B,calcium voltage-gated channel subunit alpha1 B,LEVETIRACETAM,Small molecule,CHEMBL1286,2.0,['NCT00160576'],MONDO_0005180,Parkinson disease
799,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",NILOTINIB,Small molecule,CHEMBL255863,2.0,['NCT03205488'],MONDO_0005180,Parkinson disease
800,CACNA1F,calcium voltage-gated channel subunit alpha1 F,ISRADIPINE,Small molecule,CHEMBL1648,2.0,"['NCT00753636', 'NCT00909545']",MONDO_0005180,Parkinson disease
801,NR1H4,nuclear receptor subfamily 1 group H member 4,URSODIOL,Small molecule,CHEMBL1551,2.0,['NCT03840005'],MONDO_0005180,Parkinson disease
802,SLC6A4,solute carrier family 6 member 4,TESOFENSINE,Small molecule,CHEMBL3989690,2.0,"['NCT00148486', 'NCT00148512']",MONDO_0005180,Parkinson disease
803,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
804,GRM5,glutamate metabotropic receptor 5,MAVOGLURANT,Small molecule,CHEMBL3087515,2.0,"['NCT00582673', 'NCT01092065', 'NCT00986414']",MONDO_0005180,Parkinson disease
805,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT01172379', 'NCT00165789']",MONDO_0005180,Parkinson disease
806,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
807,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT04879134'],MONDO_0005180,Parkinson disease
808,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT02702076'],MONDO_0005180,Parkinson disease
809,MT-ND4L,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
810,CACNA1S,calcium voltage-gated channel subunit alpha1 S,ISRADIPINE,Small molecule,CHEMBL1648,2.0,"['NCT00753636', 'NCT00909545']",MONDO_0005180,Parkinson disease
811,SLC6A2,solute carrier family 6 member 2,METHYLPHENIDATE,Small molecule,CHEMBL796,2.0,['NCT00359723'],MONDO_0005180,Parkinson disease
812,NDUFAF2,NADH:ubiquinone oxidoreductase complex assembly factor 2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
813,NDUFA12,NADH:ubiquinone oxidoreductase subunit A12,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
814,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,2.0,['NCT02103465'],MONDO_0005180,Parkinson disease
815,ADRA1A,adrenoceptor alpha 1A,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
816,NDUFS4,NADH:ubiquinone oxidoreductase subunit S4,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
817,BCR,BCR activator of RhoGEF and GTPase,NILOTINIB HYDROCHLORIDE MONOHYDRATE,Small molecule,CHEMBL1201740,2.0,['NCT02954978'],MONDO_0005180,Parkinson disease
818,ADRB3,adrenoceptor beta 3,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT03567447'],MONDO_0005180,Parkinson disease
819,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,['NCT00451633'],MONDO_0005180,Parkinson disease
820,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00610103', 'NCT01693081', 'NCT00346827', 'NCT00040209', 'NCT03292016', 'NCT00200512', 'NCT02228590', 'NCT01683292', 'NCT03187301']",MONDO_0005180,Parkinson disease
821,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,PERAMPANEL,Small molecule,CHEMBL1214124,2.0,"['NCT00165789', 'NCT01172379']",MONDO_0005180,Parkinson disease
822,GRIK4,glutamate ionotropic receptor kainate type subunit 4,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
823,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT01538329'],MONDO_0005180,Parkinson disease
824,MMP7,matrix metallopeptidase 7,DOXYCYCLINE,Small molecule,CHEMBL1200699,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
825,ADORA2A,adenosine A2a receptor,TOZADENANT,Small molecule,CHEMBL2105747,2.0,"['NCT00605553', 'NCT01283594']",MONDO_0005180,Parkinson disease
826,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,ZOLPIDEM,Small molecule,CHEMBL911,2.0,['NCT03621046'],MONDO_0005180,Parkinson disease
827,ADRA1B,adrenoceptor alpha 1B,DROXIDOPA,Small molecule,CHEMBL2103827,2.0,['NCT02812147'],MONDO_0005180,Parkinson disease
828,GABBR1,gamma-aminobutyric acid type B receptor subunit 1,SODIUM OXYBATE,Small molecule,CHEMBL1200682,2.0,"['NCT00641186', 'NCT02111122']",MONDO_0005180,Parkinson disease
829,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,2.0,['NCT02347059'],MONDO_0005180,Parkinson disease
830,DRD3,dopamine receptor D3,APOMORPHINE,Small molecule,CHEMBL53,2.0,['NCT02702076'],MONDO_0005180,Parkinson disease
831,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,2.0,"['NCT00558337', 'NCT01568034', 'NCT01766258', 'NCT00918177', 'NCT00253084', 'NCT01296464', 'NCT03007888', 'NCT01515410', 'NCT03103399', 'NCT01479127', 'NCT01568047', 'NCT01399905', 'NCT00279825', 'NCT01617135', 'NCT03541356', 'NCT02577523', 'NCT01171313', 'NCT00200447', 'NCT02271503', 'NCT00745277', 'NCT01883505', 'NCT04778176']",MONDO_0005180,Parkinson disease
832,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,ZURANOLONE,Small molecule,CHEMBL4105630,2.0,['NCT03000569'],MONDO_0005180,Parkinson disease
833,DRD2,dopamine receptor D2,APOMORPHINE,Small molecule,CHEMBL53,2.0,"['NCT00472355', 'NCT00758368']",MONDO_0005180,Parkinson disease
834,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
835,GLP1R,glucagon like peptide 1 receptor,NLY-01,Unknown,CHEMBL4650495,2.0,['NCT04154072'],MONDO_0005180,Parkinson disease
836,CA4,carbonic anhydrase 4,TOPIRAMATE,Small molecule,CHEMBL220492,2.0,['NCT00296959'],MONDO_0005180,Parkinson disease
837,DRD4,dopamine receptor D4,SARIZOTAN HYDROCHLORIDE,Small molecule,CHEMBL2146110,2.0,['NCT00009048'],MONDO_0005180,Parkinson disease
838,GABBR2,gamma-aminobutyric acid type B receptor subunit 2,OXYBATE,Small molecule,CHEMBL1342,2.0,"['NCT02111122', 'NCT00641186']",MONDO_0005180,Parkinson disease
839,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,2.0,"['NCT00434304', 'NCT00460148']",MONDO_0005180,Parkinson disease
840,CHRM3,cholinergic receptor muscarinic 3,IPRATROPIUM,Small molecule,CHEMBL1621597,2.0,['NCT00296946'],MONDO_0005180,Parkinson disease
841,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,TRAXOPRODIL,Small molecule,CHEMBL17350,2.0,['NCT00163085'],MONDO_0005180,Parkinson disease
842,NDUFC2,NADH:ubiquinone oxidoreductase subunit C2,METFORMIN,Small molecule,CHEMBL1431,2.0,['NCT05781711'],MONDO_0005180,Parkinson disease
843,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,AMANTADINE,Small molecule,CHEMBL660,2.0,['NCT00600093'],MONDO_0005180,Parkinson disease
844,HTR2A,5-hydroxytryptamine receptor 2A,QUETIAPINE,Small molecule,CHEMBL716,2.0,['NCT04164758'],MONDO_0005180,Parkinson disease
845,GRM4,glutamate metabotropic receptor 4,FOLIGLURAX,Small molecule,CHEMBL4089083,2.0,['NCT03162874'],MONDO_0005180,Parkinson disease
846,SCN4A,sodium voltage-gated channel alpha subunit 4,ZONISAMIDE,Small molecule,CHEMBL750,2.0,['NCT01766128'],MONDO_0005180,Parkinson disease
847,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,2.0,['NCT00562198'],MONDO_0005180,Parkinson disease
848,MMP13,matrix metallopeptidase 13,DOXYCYCLINE,Small molecule,CHEMBL1200699,2.0,['NCT05492019'],MONDO_0005180,Parkinson disease
849,ADRA2A,adrenoceptor alpha 2A,FIPAMEZOLE,Small molecule,CHEMBL1255582,2.0,['NCT00559871'],MONDO_0005180,Parkinson disease
850,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03440112', 'NCT03462641']",MONDO_0005180,Parkinson disease
851,ADORA2A,adenosine A2a receptor,PBF-509,Small molecule,CHEMBL3694769,1.0,"['NCT02111330', 'NCT01691924']",MONDO_0005180,Parkinson disease
852,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,['NCT04183634'],MONDO_0005180,Parkinson disease
853,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03440112', 'NCT03462641']",MONDO_0005180,Parkinson disease
854,MAOB,monoamine oxidase B,RASAGILINE,Small molecule,CHEMBL887,1.0,"['NCT01652313', 'NCT01879748', 'NCT01532128', 'NCT01532141']",MONDO_0005180,Parkinson disease
855,SCN10A,sodium voltage-gated channel alpha subunit 10,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
856,GSK3B,glycogen synthase kinase 3 beta,LITHIUM CARBONATE,Small molecule,CHEMBL1200826,1.0,['NCT04273932'],MONDO_0005180,Parkinson disease
857,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
858,BCR,BCR activator of RhoGEF and GTPase,VODOBATINIB,Small molecule,CHEMBL4130229,1.0,['NCT02970019'],MONDO_0005180,Parkinson disease
859,DRD1,dopamine receptor D1,TAVAPADON,Small molecule,CHEMBL3697617,1.0,['NCT05610189'],MONDO_0005180,Parkinson disease
860,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,1.0,['NCT04249544'],MONDO_0005180,Parkinson disease
861,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
862,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03440112', 'NCT03462641']",MONDO_0005180,Parkinson disease
863,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,1.0,['NCT04332276'],MONDO_0005180,Parkinson disease
864,GRM4,glutamate metabotropic receptor 4,FOLIGLURAX,Small molecule,CHEMBL4089083,1.0,"['NCT04322227', 'NCT04175132']",MONDO_0005180,Parkinson disease
865,ADRB1,adrenoceptor beta 1,DOPAMINE,Small molecule,CHEMBL59,1.0,"['NCT02812394', 'NCT02774564', 'NCT01533077', 'NCT02169453', 'NCT02169479', 'NCT02763839', 'NCT03091868']",MONDO_0005180,Parkinson disease
866,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,1.0,"['NCT03140956', 'NCT02486432', 'NCT01070628', 'NCT00505843', 'NCT01229332', 'NCT03887884', 'NCT02170376', 'NCT03496870', 'NCT02096601', 'NCT00914602', 'NCT01484990', 'NCT00491998', 'NCT01533116', 'NCT00845000', 'NCT02312232', 'NCT02169414', 'NCT01725802', 'NCT02554734', 'NCT01519284']",MONDO_0005180,Parkinson disease
867,CSF2RA,colony stimulating factor 2 receptor subunit alpha,SARGRAMOSTIM,Protein,CHEMBL1201670,1.0,['NCT01882010'],MONDO_0005180,Parkinson disease
868,DRD1,dopamine receptor D1,MEVIDALEN,Small molecule,CHEMBL3421729,1.0,['NCT02562768'],MONDO_0005180,Parkinson disease
869,DRD1,dopamine receptor D1,TAVAPADON,Small molecule,CHEMBL3697617,1.0,"['NCT05581823', 'NCT02373072', 'NCT02224664', 'NCT04295642']",MONDO_0005180,Parkinson disease
870,DRD2,dopamine receptor D2,PRAMIPEXOLE,Small molecule,CHEMBL301265,1.0,['NCT00666653'],MONDO_0005180,Parkinson disease
871,SCN1A,sodium voltage-gated channel alpha subunit 1,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
872,PTGS1,prostaglandin-endoperoxide synthase 1,ACETAMINOPHEN,Small molecule,CHEMBL112,1.0,['NCT02305017'],MONDO_0005180,Parkinson disease
873,SNCA,synuclein alpha,PRASINEZUMAB,Antibody,CHEMBL4298077,1.0,"['NCT02095171', 'NCT02157714']",MONDO_0005180,Parkinson disease
874,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
875,SCN8A,sodium voltage-gated channel alpha subunit 8,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
876,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,1.0,['NCT03250117'],MONDO_0005180,Parkinson disease
877,NR1H4,nuclear receptor subfamily 1 group H member 4,URSODIOL,Small molecule,CHEMBL1551,1.0,['NCT02967250'],MONDO_0005180,Parkinson disease
878,DRD5,dopamine receptor D5,TAVAPADON,Small molecule,CHEMBL3697617,1.0,['NCT05610189'],MONDO_0005180,Parkinson disease
879,ADORA2A,adenosine A2a receptor,CAFFEINE,Small molecule,CHEMBL113,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
880,DRD3,dopamine receptor D3,ROPINIROLE,Small molecule,CHEMBL589,1.0,"['NCT01435915', 'NCT01371682']",MONDO_0005180,Parkinson disease
881,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,1.0,"['NCT01371682', 'NCT01435915']",MONDO_0005180,Parkinson disease
882,SCN4A,sodium voltage-gated channel alpha subunit 4,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
883,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,1.0,['NCT00666653'],MONDO_0005180,Parkinson disease
884,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,['NCT04183634'],MONDO_0005180,Parkinson disease
885,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,['NCT04183634'],MONDO_0005180,Parkinson disease
886,SCN7A,sodium voltage-gated channel alpha subunit 7,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
887,RXRA,retinoid X receptor alpha,IRX-4204,Small molecule,CHEMBL75133,1.0,['NCT02438215'],MONDO_0005180,Parkinson disease
888,ADORA2A,adenosine A2a receptor,ISTRADEFYLLINE,Small molecule,CHEMBL431770,1.0,['NCT02174250'],MONDO_0005180,Parkinson disease
889,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,1.0,['NCT04127578'],MONDO_0005180,Parkinson disease
890,DRD3,dopamine receptor D3,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,"['NCT00292227', 'NCT02055274', 'NCT02230904', 'NCT04045678', 'NCT01964573', 'NCT02728947', 'NCT04384666', 'NCT04044547', 'NCT01338896']",MONDO_0005180,Parkinson disease
891,RXRB,retinoid X receptor beta,IRX-4204,Small molecule,CHEMBL75133,1.0,['NCT02438215'],MONDO_0005180,Parkinson disease
892,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,REPAGLINIDE,Small molecule,CHEMBL1272,1.0,['NCT01536366'],MONDO_0005180,Parkinson disease
893,FKBP1A,FKBP prolyl isomerase 1A,SIROLIMUS,Small molecule,CHEMBL413,1.0,['NCT04127578'],MONDO_0005180,Parkinson disease
894,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03440112', 'NCT03462641']",MONDO_0005180,Parkinson disease
895,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,1.0,"['NCT04591535', 'NCT04513340', 'NCT05128175']",MONDO_0005180,Parkinson disease
896,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
897,GFRA1,GDNF family receptor alpha 1,LIATERMIN,Protein,CHEMBL2108380,1.0,"['NCT00111982', 'NCT00115427']",MONDO_0005180,Parkinson disease
898,SCN3A,sodium voltage-gated channel alpha subunit 3,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
899,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,1.0,"['NCT02312232', 'NCT03496870', 'NCT02169414', 'NCT01725802', 'NCT02486432', 'NCT00505843', 'NCT02096601', 'NCT02554734', 'NCT03887884', 'NCT01229332', 'NCT00914602', 'NCT01484990', 'NCT03140956', 'NCT00845000', 'NCT01533116', 'NCT00491998', 'NCT01519284', 'NCT02170376', 'NCT01070628']",MONDO_0005180,Parkinson disease
900,SNCA,synuclein alpha,CINPANEMAB,Antibody,CHEMBL3833330,1.0,['NCT02459886'],MONDO_0005180,Parkinson disease
901,COMT,catechol-O-methyltransferase,OPICAPONE,Small molecule,CHEMBL1089318,1.0,"['NCT03496870', 'NCT03116295', 'NCT03116308', 'NCT03820037', 'NCT04265027']",MONDO_0005180,Parkinson disease
902,VKORC1,vitamin K epoxide reductase complex subunit 1,WARFARIN,Small molecule,CHEMBL1464,1.0,"['NCT02305030', 'NCT02169440']",MONDO_0005180,Parkinson disease
903,SCN9A,sodium voltage-gated channel alpha subunit 9,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
904,ADRA1A,adrenoceptor alpha 1A,TERAZOSIN,Small molecule,CHEMBL611,1.0,['NCT03905811'],MONDO_0005180,Parkinson disease
905,DRD3,dopamine receptor D3,MESDOPETAM,Small molecule,CHEMBL4594447,1.0,['NCT03531060'],MONDO_0005180,Parkinson disease
906,SCN11A,sodium voltage-gated channel alpha subunit 11,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
907,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,NICOTINE,Small molecule,CHEMBL3,1.0,['NCT00957918'],MONDO_0005180,Parkinson disease
908,DRD4,dopamine receptor D4,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,"['NCT01338896', 'NCT04384666', 'NCT01964573', 'NCT02230904', 'NCT04044547', 'NCT00292227', 'NCT02055274', 'NCT04045678', 'NCT02728947']",MONDO_0005180,Parkinson disease
909,DRD4,dopamine receptor D4,PRAMIPEXOLE,Small molecule,CHEMBL301265,1.0,['NCT04249544'],MONDO_0005180,Parkinson disease
910,DRD2,dopamine receptor D2,ROTIGOTINE,Small molecule,CHEMBL1303,1.0,"['NCT02728947', 'NCT01964573', 'NCT02055274', 'NCT04045678', 'NCT04044547', 'NCT02230904', 'NCT00292227', 'NCT04384666', 'NCT01338896']",MONDO_0005180,Parkinson disease
911,DRD5,dopamine receptor D5,TAVAPADON,Small molecule,CHEMBL3697617,1.0,"['NCT05581823', 'NCT02224664', 'NCT04295642', 'NCT02373072']",MONDO_0005180,Parkinson disease
912,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03440112', 'NCT03462641']",MONDO_0005180,Parkinson disease
913,ADORA2A,adenosine A2a receptor,PRELADENANT,Small molecule,CHEMBL240624,1.0,"['NCT01323855', 'NCT00845000']",MONDO_0005180,Parkinson disease
914,ABCC8,ATP binding cassette subfamily C member 8,REPAGLINIDE,Small molecule,CHEMBL1272,1.0,['NCT01536366'],MONDO_0005180,Parkinson disease
915,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1200748,1.0,"['NCT04513340', 'NCT04591535', 'NCT05128175']",MONDO_0005180,Parkinson disease
916,TRPV1,transient receptor potential cation channel subfamily V member 1,ACETAMINOPHEN,Small molecule,CHEMBL112,1.0,['NCT02305017'],MONDO_0005180,Parkinson disease
917,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,1.0,['NCT03119636'],MONDO_0005180,Parkinson disease
918,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,ROSUVASTATIN,Small molecule,CHEMBL1496,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
919,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03462641', 'NCT03440112']",MONDO_0005180,Parkinson disease
920,CSF2RA,colony stimulating factor 2 receptor subunit alpha,SARGRAMOSTIM,Protein,CHEMBL1201670,1.0,['NCT03790670'],MONDO_0005180,Parkinson disease
921,DRD2,dopamine receptor D2,ORDOPIDINE,Small molecule,CHEMBL3545010,1.0,['NCT01023282'],MONDO_0005180,Parkinson disease
922,ADORA1,adenosine A1 receptor,CAFFEINE,Small molecule,CHEMBL113,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
923,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,1.0,['NCT03250117'],MONDO_0005180,Parkinson disease
924,GRM4,glutamate metabotropic receptor 4,FOLIGLURAX,Small molecule,CHEMBL4089083,1.0,['NCT02639221'],MONDO_0005180,Parkinson disease
925,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,NICOTINE,Small molecule,CHEMBL3,1.0,['NCT00957918'],MONDO_0005180,Parkinson disease
926,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,FLUMAZENIL,Small molecule,CHEMBL407,1.0,"['NCT03462641', 'NCT03440112']",MONDO_0005180,Parkinson disease
927,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",VODOBATINIB,Small molecule,CHEMBL4130229,1.0,['NCT02970019'],MONDO_0005180,Parkinson disease
928,SCN2A,sodium voltage-gated channel alpha subunit 2,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
929,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
930,SNCA,synuclein alpha,CINPANEMAB,Antibody,CHEMBL3833330,1.0,['NCT03716570'],MONDO_0005180,Parkinson disease
931,EPOR,erythropoietin receptor,EPOETIN BETA,Protein,CHEMBL2109092,1.0,['NCT01010802'],MONDO_0005180,Parkinson disease
932,ADORA2B,adenosine A2b receptor,CAFFEINE,Small molecule,CHEMBL113,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
933,ADRA1D,adrenoceptor alpha 1D,TERAZOSIN,Small molecule,CHEMBL611,1.0,['NCT03905811'],MONDO_0005180,Parkinson disease
934,SCN5A,sodium voltage-gated channel alpha subunit 5,CARBAMAZEPINE,Small molecule,CHEMBL108,1.0,['NCT05581823'],MONDO_0005180,Parkinson disease
935,IMPA1,inositol monophosphatase 1,LITHIUM CARBONATE,Small molecule,CHEMBL1200826,1.0,['NCT04273932'],MONDO_0005180,Parkinson disease
936,DRD4,dopamine receptor D4,ROPINIROLE,Small molecule,CHEMBL589,1.0,['NCT03250117'],MONDO_0005180,Parkinson disease
937,ADRA1B,adrenoceptor alpha 1B,TERAZOSIN,Small molecule,CHEMBL611,1.0,['NCT03905811'],MONDO_0005180,Parkinson disease
938,DRD3,dopamine receptor D3,LEVODOPA,Small molecule,CHEMBL1009,1.0,"['NCT02807675', 'NCT01533116', 'NCT02486432', 'NCT00845000', 'NCT02170376', 'NCT01519284', 'NCT02812394', 'NCT00505843', 'NCT01725802', 'NCT03496870', 'NCT02554734', 'NCT03140956', 'NCT03887884', 'NCT03205956', 'NCT01484990', 'NCT02778594', 'NCT01070628', 'NCT02096601', 'NCT02312232', 'NCT00914602', 'NCT02169414', 'NCT01026428']",MONDO_0005180,Parkinson disease
939,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,1.0,['NCT04249544'],MONDO_0005180,Parkinson disease
940,MPO,myeloperoxidase,VERDIPERSTAT,Small molecule,CHEMBL4297594,1.0,['NCT01457807'],MONDO_0005180,Parkinson disease
941,PTGS2,prostaglandin-endoperoxide synthase 2,ACETAMINOPHEN,Small molecule,CHEMBL112,1.0,['NCT02305017'],MONDO_0005180,Parkinson disease
942,DRD3,dopamine receptor D3,PRAMIPEXOLE,Small molecule,CHEMBL301265,1.0,['NCT00666653'],MONDO_0005180,Parkinson disease
943,GSK3A,glycogen synthase kinase 3 alpha,LITHIUM CARBONATE,Small molecule,CHEMBL1200826,1.0,['NCT04273932'],MONDO_0005180,Parkinson disease
944,DDC,dopa decarboxylase,BENSERAZIDE,Small molecule,CHEMBL1096979,1.0,"['NCT02778594', 'NCT01533116', 'NCT02169414']",MONDO_0005180,Parkinson disease
945,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
946,MAOB,monoamine oxidase B,SAFINAMIDE,Small molecule,CHEMBL396778,1.0,['NCT01026428'],MONDO_0005180,Parkinson disease
947,DDC,dopa decarboxylase,CARBIDOPA,Small molecule,CHEMBL1201236,1.0,"['NCT05128175', 'NCT04591535', 'NCT04513340']",MONDO_0005180,Parkinson disease
948,DRD2,dopamine receptor D2,ROPINIROLE,Small molecule,CHEMBL589,1.0,"['NCT01371682', 'NCT01435915']",MONDO_0005180,Parkinson disease
949,RXRG,retinoid X receptor gamma,IRX-4204,Small molecule,CHEMBL75133,1.0,['NCT02438215'],MONDO_0005180,Parkinson disease
950,GLP1R,glucagon like peptide 1 receptor,EXENATIDE,Protein,CHEMBL414357,1.0,['NCT03456687'],MONDO_0005180,Parkinson disease
951,ADORA3,adenosine A3 receptor,CAFFEINE,Small molecule,CHEMBL113,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
952,COMT,catechol-O-methyltransferase,NEBICAPONE,Small molecule,CHEMBL160038,1.0,"['NCT02772627', 'NCT03097211']",MONDO_0005180,Parkinson disease
953,ADORA2A,adenosine A2a receptor,CIFORADENANT,Small molecule,CHEMBL4297184,1.0,"['NCT02764892', 'NCT01634568']",MONDO_0005180,Parkinson disease
954,FAAH,fatty acid amide hydrolase,ACETAMINOPHEN,Small molecule,CHEMBL112,1.0,['NCT02305017'],MONDO_0005180,Parkinson disease
955,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,MIDAZOLAM,Small molecule,CHEMBL655,1.0,['NCT03970798'],MONDO_0005180,Parkinson disease
956,COMT,catechol-O-methyltransferase,ENTACAPONE,Small molecule,CHEMBL953,1.0,"['NCT00491998', 'NCT02169440', 'NCT02170376', 'NCT03091868', 'NCT02101190', 'NCT02169466', 'NCT02305316', 'NCT01532115', 'NCT02169414', 'NCT02071810', 'NCT02554734', 'NCT01070628', 'NCT02169479', 'NCT01520727', 'NCT02169453', 'NCT02305017', 'NCT02305277', 'NCT01533077', 'NCT01520987', 'NCT01532141', 'NCT01533116', 'NCT03094156', 'NCT02071823', 'NCT01515891', 'NCT01532128', 'NCT03820037', 'NCT03119194', 'NCT02169895', 'NCT02092168', 'NCT01519284', 'NCT01536366', 'NCT02305030']",MONDO_0005180,Parkinson disease
